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Abstract 
 
A large number of proteins have shown ability to bind to SUMO (Small 
Ubiquitin like Modifier) proteins through a short conserved motif called SIM (SUMO 
Interacting Motif).  
The work presented here shows that the different SUMO isoforms interact with 
the hydrophobic core of the SIM by forming an intermolecular β-sheet with the β2 
strand of SUMO. This interaction is crucial for SUMO binding, and is modulated by 
interactions between SUMO and the amino acids flanking the core of the SIM. The 
SIM can be phosphorylated, providing a possibility for regulating the strength of 
SUMO binding in the lifetime of a protein. Furthermore, a concentration threshold 
effect is observed in the binding of the unphosphorylated SIM of PIAS (Protein 
inhibitor of activated STAT) to SUMO. The dependency on the amino acids flanking 
the hydrophobic core is stronger in binding to SUMO1 than to SUMO2, providing a 
mechanism for SUMO isoform discrimination.  
 
Zusammenfassung 
 
 Viele Proteine haben die Fähigkeit an SUMO (Small Ubiquitin like Modifier) 
Proteine durch ein kleines konserviertes Motiv zu binden. Dieses Motiv wird SIM 
(SUMO Interacting Motif) genannt.  
 Diese Arbeit zeigt, dass der hydrophobe Kern des SIM mit den verschiedenen 
SUMO Isoformen interagiert, indem er mit dem β2 Strang von SUMO ein 
intermolekulares β-Faltblatt formt. Diese Wechselwirkung ist für die Bindung an 
SUMO essenziell und wird von Interaktionen zwischen SUMO und Aminosäuren, 
welche das SIM flankieren, verstärkt. Das SIM kann phosphoryliert werden, wodurch 
die Affinität der Bindung an SUMO während der Lebenszeit eines Proteins reguliert 
werden kann. Die flankierenden Aminosäuren des SIMs spielen eine größere Rolle 
bei der Bindung an SUMO1 als an SUMO2, was einen SUMO Isoform 
Diskriminierungsmechanismus  darstellt.  
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Abbreviations 
 
cDNA: Complementary Desoxyribonucleic Acid  
EST: Expressed Sequence Tag 
FID: Free Induced Decay 
GSH: Glutathion (reduced form)  
HEK293T: Human Embryonic Kidney cell line in which the gene for the temperature 
sensitive SV-40 T antigene was inserted.  
HSQC: Heteronuclear Single Quantum Coherence 
IPTG: Isopropyl-β-D-Thiogalactopyranoside 
Ke: exhange constant (equivalent to KD for individual atoms or chemical groups in a 
macromolecule) 
KD: Dissociation constant 
Kon: association rate 
Kex: dissociation rate 
LB: Luria Bertani  
MALDI: Matrix Assisted Laser Desorbtion Ionisation  
NMR: Nuclear Magnetic Resonance  
PBS: Phosphate Buffer Saline  
PCR: Polymerase Chain Reaction  
PDB: Protein DataBase (see www.rcsb.org)  
PIAS: Protein Inhibitor of Activated STAT 
SDS-PAGE: Sodium Dodecyl Sulfate – Poly Acrylamide Gel Electrophoresis  
SIM: SUMO Interacting Motif  
SUMO: Small Ubiquitin like Modifier 
TDG: Thymin DNA Glycosidase  
TTRAP: TRAF and TNF Receptor Associated Protein 
2YT: Yeast Trypton, 2x concentrated 
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I) Nuclear Magnetic Resonance  
 
NMR (Nuclear Magnetic Resonance) is the primary method used in the work 
presented here. It will therefore be presented shortly in this section. NMR is to date 
the only available technique to observe the behavior of molecules in solution at 
atomic resolution. It relies on a property of subatomic particles called Spin. Spin is a 
property of particles, like mass, charge or magnetism. But unlike mass, charge or 
magnetism, Spin is not observable in the macroscopic world, making it impossible for 
us to have a “real life” experience of it. This makes Spin physics especially difficult to 
understand. Too many exciting things happen when a molecule is placed in a pulsed 
magnetic field to be described in detail in the introduction of a PhD thesis. The 
following section will describe only the basic principles of the experiments used in the 
present work.  
 
1. Nature of Spin 
 
 The existence of Spin was 
proposed in 1925 by Goudsmit 
and Uhlenbeck, and 
demonstrated in 1928 by Dirac 
(fig. 1). They showed that 
electrons behave as if they were 
tiny charged balls rotating about 
their own axis and thus creating, 
due to their charge, a magnetic 
field. This behavior is the manifestation of the Spin of the electrons, and has nothing 
to do with actual rotation of the electrons around themselves – even if this image is 
widely used in textbooks. Like electrons, neutrons and protons also have Spin.  
 Spin is quantified, comes in multiples of ½ and can be either positive or 
negative. This means the value of the Spin of a particle is either +½ or -½. In atoms, 
electrons, protons and neutrons fill orbitals following the “Aufbau principle”. As a 
result, atoms have a net electronic Spin –the sum of the unpaired electron Spins- and 
a net nuclear Spin –the sum of the unpaired protons and neutrons Spins. Some 
Fig. 1: from left to right George Uhlenbeck, Hendrik Kramers, Samuel 
Goudsmit and Paul Dirac 
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Nuclei have no Spin, others have a Spin ½, and others have even higher Spin (1, 
3/2, etc…).  
 
2. Principle of NMR 
 
Placed in a magnetic field, a 
nucleus with Spin ½ can occupy two 
different energy states: Spin up (+½) 
and Spin down (-½). A convenient 
visualization is to consider such an 
nucleus as a magnet placed parallel 
(Spin down) or antiparallel (Spin up) 
to an exterior magnetic field. The 
energy difference between both 
states depends on the strength of the 
exterior  magnetic field (fig. 2), and 
on the type of Nucleus (13C, 1H, 
15N…) Transition between those 
states is spontaneous.  When a 
nucleus is placed in a magnetic field, 
its Spin tends to point in the same 
direction as the surrounding magnetic field, and transition to the opposite direction is 
possible upon irradiation of the nucleus with a radiofrequency which wavelength 
corresponds to the difference of energy between the two Spin states. An accurate 
description of the behavior of individual Spins in the course of NMR experiments is 
out of the scope of this introduction. What matters in an experiment is the behaviour 
of a population of Spins as a whole. Placed in an exterior magnetic field B0, a 
population of Spins produces a magnetic field B1 parallel to B0. By using an 
appropriate sequence of radiofrequency excitations (“pulse sequence), B1 can be 
tipped at 90° relatively to B0. After the end of the pulse sequence, B1 returns to its 
original position in a complex motion that involves turning about B0 and bringing the 
(B0, B1) angle from 90° to 0° (fig. 3). This creates an alternative current of decreasing 
intensity in a coil placed perpendicularly to B0, which is the signal measured in NMR. 
This signal is called FID (Free Induced decay). Fourier transformation can be used to 
Fig. 2: the energy difference between the two states of a Spin 
–parallel to the environing magnetic field (blue) or antiparallel 
to it (red)- depends on the strength of this field.  
Intensity of environing
magnetic field
En
e
rg
y
0
Particle with Spin ½. The
arrow points in the direction 
of the associated magnetic
field
Environing magnetic field B0
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extract the frequencies contained in the FID and produced a NMR spectrum in which 
the peaks correspond to the absorbed by the Spin populations present in the sample 
(resonance frequencies). Expressed in Hz, those frequencies are very large, and 
depend on the strength of the magnetic field emitted by the spectrometer. This is why 
one preferably expresses the 
resonance frequencies in ppm.  
 
3. 1D NMR 
 
 If the resonance of nuclei 
was dependent only on the type of 
nuclei and the magnetic field 
applied by the spectrometer, all  
B0
FT
time
in
te
n
sit
y
in
te
n
sit
y
frequency
a)
b)
Fig. 3: a) After a pulse, the a population of Spin that has been oriented perpendicularly to the surrounding magnetic field B0 
(red arrow) comes back to its equilibrium position parallel to B0 (blue arrow), following the path shown in green. This 
movement of the Spin population induces an oscillating signal (b, left) called FID in a the detector coil placed 
perpendicularly to B0. Fourier transformation (FT) is used to convert the FID into a NMR spectrum (b, right).  
Fig. 4: A magnetic field B0 induces the electronic clouds of the 
different atoms of an ethanol molecule to create magnetic fields of 
opposite direction. Each nucleus experiences the local sum of the 
applied field and the various induced fields.  
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the hydrogen atoms of a macromolecule such as a protein would give the same 
signal, and no information on the macromolecule could be gained. This is, however, 
not the case. Since the electrons of the molecule are able to move, the applied 
magnetic field causes them to do so in a way that creates a magnetic field that 
counters the applied one, as described by the induction law. The intensity of this 
induced magnetic field varies within the molecule. Thus, each nucleus in a molecule 
is subjected to a magnetic field created by the atoms surrounding it (fig. 4).  During 
an NMR experiment, a nucleus doesn’t “feel” only the magnetic field created by the 
spectrometer, but the sum of the local magnetic field created by the molecule and the 
magnetic field generated by the spectrometer. Therefore, the different 13C, 1H and 15N 
nuclei of a molecule absorb and reemit photons of different energies (they have 
different resonance frequencies) giving distinct NMR signals (fig. 5). In consequence, 
the 1H NMR spectrum of a protein contains as many peaks as there are hydrogen 
atoms in that protein. There are, of course, many of them, and such a spectrum is 
very complex, with most peaks overlapping each other. To overcome this complexity,  
Fig. 5: Different techniques can be used to spread a one dimensional spectrum (a) over 2 dimensions (b), three 
dimensions (c) or more. In a), the resonance frequency (RF) is on the horizontal axis and the intensity on the vertical axis. 
In b) the resonance frequencies are on the horizontal axes and the intensity on the vertical axis. Peaks appear as cones (in 
orange, the original 1D spectra is shown in green). In c), the resonance frequencies are along the three axes, and peaks 
appear as spheres which diameter is proportional to the intensity (in violet, the original 2D peaks being shown in orange). 
Note how peak overlap is reduced by increasing the number of dimensions. 
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2D and 3D NMR techniques have been developed. In such spectra, e a 1D spectrum 
is spread out over one or more extra dimension: instead of having n peaks along one 
axis, those n peaks are scattered over a surface or in a volume (fig. 5).  
 
4. 2D NMR can be used to 
observe structural changes 
in a protein 
 
 A very useful type of 
2D NMR experiment in 
protein sciences is the 
HSQC (Heteronuclear Single 
Quantum Coherence) 
experiment. This experiment 
requires all nitrogen atoms in 
the sample protein to be 15N. 
The way the sample is irradiated (pulse sequence) allows to observe the resonance 
frequencies of hydrogen and nitrogen atoms involved in N-H bonds. In the resulting 
HSQC spectrum, a NH group 
will be observed as a peak 
at the resonance frequencies 
of its Hydrogen and Nitrogen 
atoms (fig. 6).   
 Such a spectrum of a 
protein can be measured in 
few hours (the higher the 
concentration, the less 
measuring time is needed to 
generate data of adequate 
quality). Alone, a HSQC 
spectrum of a protein is of 
little interest. It gives an idea 
of the α-Helix and β-strand 
content of a protein, or of whether the protein is aggregated, but little else. The great 
Fig. 6: a) Two amino acids of a protein with their amide groups highlighted in 
red. b) the peaks obtained for those amide groups in a HSQC spectrum in 
the usual “level curves” representation. Real HSQC spectra are presented in 
Fig.7 
NH-C4H8-CH
_
_
H-N
C=O
H 3C-CH
_
_
H-N
C=O
_
_
C=O
Ala n+1
Lys n
Lys n 
sidechain
1H resonance
15N resonnance
Lys n
Lys n
Ala 
n+1
Ala n+1
Lys n 
sidechain
a) b)
Fig. 7: Example of use of HSQC Spectra for investigating the effect of 
conditions changes on a protein. In this case, spectra of non sumoylated 
(red) and Sumoylated (blue) RanGap1 have been overlaid. The limited extent 
of the differences between both shows that Sumoylation has little effect on 
the overall structure of RanGap1 (see also the section “interactions of SUMO 
with other proteins).  
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interest of HSQC spectra is for monitoring structural changes in a protein. Changes in 
the structure of a protein mean that the relative position of its atoms and their 
electronic clouds change as well. This results in changes in the local magnetic fields 
experienced by the various nuclei. Hence, structural changes can be seen in NMR as 
shifts of the resonance frequencies of the nuclei of a protein. In HSQC, these are 
observed as changes of the position of the corresponding peaks. Binding of a ligand 
to a protein can be monitored by this method because it changes the local magnetic 
field of the protein directly –as any molecule, a ligand generates a magnetic field- 
and indirectly by inducing structural changes in the protein (fig. 7).  
 
 
5. 3D NMR and the assignment of the resonances of a protein  
 
 We have seen in the previous section that 2D NMR spectra can be used to 
investigate structural changes in proteins, by observing the effect of condition 
changes on the resonance frequencies of Hydrogen and Nitrogen nuclei. More 
detailed information is available in such spectrum if one is able to determine to which 
amino acid of the protein corresponds each peak in the spectrum. Unfortunately, 
such information cannot be derived from the HSQC spectra themselves, and other 
types of spectra have to be analyzed to assign the observed resonance to the amino 
acids they come from. In the “good old days” – a mere decade ago- two dimensional 
spectra were used. Technical progress has brought about new methods and better 
_
_
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_
_
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n
R -Cβ-CαH
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_
_
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_
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n
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a)                b)                   c)                   d)                  e)                 f)                   g) 
Fig. 8: atoms visible in different types of spectra for a generic dipeptide within a 15N 13C marked protein. Note that the 
projection of each of those spectra (except the HN(CO)CA) onto the 1H15N plan amounts to a HSQC spectrum. a) HNCACB 
b) HNCO c) HN(CO)CA d) HC(CO)NH e) HNHA f) C(CO)NH g) (HCA)CO(CA)NH.  
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performing spectrometers to apply them, and the easiest way to assign resonances 
to their amino acids is to use a set of three dimensional spectra.  
 The productions of those spectra require that all the carbons in the protein are 
13C and all the nitrogens 15N. The resulting spectra have 3 axes, one for the Carbon 
resonances, one for the nitrogen resonances and one for the hydrogen resonances. 
By using different pulse sequences, one can select the atoms that will be observed, 
as shown in fig. 8.  
Ideally the assignment of 
the protein backbone can be 
produced using only a HNCACB 
spectrum. In this spectrum, peaks 
come in quartets, as shown on fig. 
9. A quartet is composed of four 
peaks that have the same N and 
H resonances. Those resonances 
correspond to the amine group of 
the nth amino acid in the 
sequence. The two big peaks of 
the quartet correspond to the 
resonances of the Cα and Cβ 
atoms of the amino acid, the two 
smaller peaks to the resonances 
of the Cα and Cβ  atoms of the (n-
1th) amino acid. As the usual 
resonance ranges for the Cα and Cβ  resonance frequencies of the various amino 
acids are known, it is possible to make hypothesis on the nature of each the two 
amino acids observed in a quartet of peaks. Generally, there are less than half a 
dozen of possibilities for a pair of peaks. This gives a certain number of possible 
combinations for a quartet of peaks. However, most of those combinations are not 
found in the sequence of the studied protein, and usually one is left with one or two 
assignment alternatives for a quartet. Quartets can also be sequentially ordered, 
taking advantage that the amino acid n-1 is observed giving peaks at the same 13C 
coordinates in two quartets: it corresponds to the two small peaks in the [n; n-1] 
15N
1H
13C
Am
in
o 
Ac
id
 
n
-
1
Am
in
o
 
Ac
id
 
n
Am
in
o
 
Ac
id
 
n
-
2
Fig. 9: two “quartets” of peaks in an HNCACB spectrum.  The Cα and 
Cβ of an amino acid give peaks of similar intensity with opposite signs 
(color coded as red and blue). The amino acid number n-1 appears 
twice in the spectrum, once as the two bigger peaks of a quartet, and 
once as the two smaller ones in another quartet. Its Cα and Cβ 
having the same coordinates in both quartets, the quartets can be 
sequencially ordered.  
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quartet, and to the two big peaks in the [n-1; n-2] quartet (fig. 9). Other types of 3D 
spectra may be used when there are ambiguities or lacunes in the HNCACB 
spectrum, and, when the assignment of the protein backbone is known, to assign the 
resonances of the atoms that are not observed in the HNCACB spectrum (i.e. the 
carbon in the C=O group of the peptide bond and the Carbon, Nitrogen and 
Hydrogen atoms in the side chains of the amino acids).  
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II) SUMOylation 
 
1. Post-translational Modifications  
 
When the human genome was published in February 2001 [International 
Genome Sequencing Consortium, 2001], the greatest surprise came from the 
number of genes found in it. The news that a few tens of thousands of proteins –ten 
time less than what was usually expected- suffice to assure the functions required for 
perpetuating human life was welcomed by general incredulity: how could the 
combination of so few individual functions result in such a complex organism as a 
human being? A Jumbo Jet is assembled from some 200000 types of parts, and is 
comparatively extremely simple.  
One has, however, to consider that, for various reasons a gene usually codes 
for more than one function. Each gene may code for more than one protein (due to 
alternative splicing). Most proteins are composed of several domains, each having 
one or more functions. Furthermore, each protein can be, in the course of its life, 
subjected to post-translational modifications in response to intracellular events or 
changes in extracellular conditions.  
 Post-translational modification is defined a physiological change in the 
arrangement of covalent bonds in a protein, without counting the chemical bonds 
formations implied by enzymatic mechanisms. This includes cross linking reactions 
between the amino acids of a protein (as in GFP and proteins containing disulfide 
bridges), the removal of parts of a protein (as in insulin) and the covalent binding of a 
chemical compound to a protein. Protein constitutively containing a non covalently 
bound chemical compound required for their function and structural integrity (as 
hemoglobin with haem or rhodobsin with carotene) may be regarded as post-
translationally modified as well. The possible chemical groups are various in nature. 
Some, as phosphate, are very small and inorganic whereas others (SUMO, 
Glycosylation…) are large organic molecules. Most post-translational modifications 
are carried out by enzymes which recognize a specific motif in a protein. Some post-
translational modifications (a good example is the Glycosylation of cartilage proteins) 
are constitutive, meaning that all the concerned proteins bear those modifications 
whatever the context. However the majority of post-translational modifications are 
carried out in response to changes in the intra- or extracellular environment.  
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 The role of post-translational modifications is to change the affinity of a protein 
to chemical compounds. This results in changes in localization (e.g. some proteins 
are attached to a lipid and thus become anchored to a membrane), enzymatic 
efficiency, ability to recognize interaction partners…  
 The recognition of the importance of phosphorylation has brought the studies 
of post-translational modifications to emerge as a major field of biological research 
since over a decade.  
 
2. Description of SUMO proteins 
 
 SUMO (Small 
ubiquitin like modifier) 
proteins have been 
discovered in the nineties 
by [Meluh & Koshland, 
1995]. They have 
received their name 
because like Ubiquitin –
and several protein 
discovered since then- 
they can be covalently 
attached to target 
proteins through an isopeptide bond (fig. 10).  
 SUMO is however not the only name given to those proteins, and the 
NH-CH2-C
=
O
_
NH-C4H8-CH
_
_
O=C
N-H
Target 
Lysin
SUMO C-terminal Glycin
Fig. 10: Sumoylated protein. The SUMO moiety is in green, the target protein in 
blue.  
Name in the 
present work
N-terminal 
amino acids alternative name database ID
Original 
publication
Name in original 
publication Gene sequence database
PDB ID of 
structure
SMT3-C_HUMAN SwissProt P63165 X99586
Entrez 
Nucleotides 
(NCBI)
SUMO1
RefSeq 
(NCBI) NP_003343 NM_003352.4 RefSeq (NCBI)
PIC1, Ubl1, 
SMT3H3, GMP1, 
Sentrin
SMT3-A_HUMAN SwissProt P55854 X99584
Entrez 
Nucleotides 
(NCBI)
SUMO3
RefSeq 
(NCBI) NP_008867 NM_006936 RefSeq (NCBI)
SMT3H1
SMT3-B_HUMAN SwissProt L76416
Entrez 
Nucleotides 
(NCBI)
SUMO2
RefSeq 
(NCBI) NP_008868 NM_006937 RefSeq (NCBI)
SMT3H2, Sentrin2
Lapenta V. et al , 
1997
Lapenta V. et al , 
1997
Mannen et al , 
1996
SMT3C
SMT3A
MIF2 Suppressor
SUMO1
SUMO2
SUMO3
MSEE...
MSDQEA...
MADEK... 
1A5R
1U4A, 
1WM3
1U4A, 
1WM3
Table 1: SUMO isoforms in the databases 
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numbering of the isoforms differs from one author to the other, which calls for caution 
when comparing data from different sources. The different nomenclatures and 
databases entries are summarized in table 1.  
 In man, three SUMO isoforms have been identified [for SUMO1 and -3, 
Lapenta et al, 1997; for SUMO2, Mannen et al, 1996]. A fourth has been reported in 
summer 2004 [Bohren et al, 2004], but whether this isoform actually exists is still the 
subject of heated discussions.  
 SUMO2 and -3 are more closely related to each other (96% identity) than to 
SUMO1 (~45% identity in both cases) (fig. 11). The structure of SUMO1 and -3 has 
been solved by different groups [Bayer 1998; Huang et al, 2004]. As the structured 
region of SUMO3 is identical to the structured region of SUMO2, it can be considered 
that the structure of SUMO2 is known as well.  
  Despite the low sequence homology between them, SUMO and Ubiquitin 
have very similar tertiary structures. This structure consists in a (-sheet made of 4 
Fig. 11: Features of SUMO proteins. a) Alignment of  human SUMO 1, 2 and 3. Structural elements are highlighted in the 
same colors as in b) and c). The Sumoylation motif in the N-terminal tail of SUMO2 and 3 is boxed, with the target lysin 
highlighted in bold. The Gly-Gly motif in the C-terminal tail is boxed as well. b) Diagram of the fold common to SUMO and 
Ubiquitin.  c) Structure of SUMO1 (PDB ID: 1A5R, Bayer et al, 1998) 
1
2
3
4
1        11         21        31        41        51
|         |          |         |         |         |       
SUMO1 MSDQEAKPSTEDLGDKKEG EYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPM 60
SUMO2 MSEE  KP KE  GVKTEN DHINLKVAGQDGSVVQFKIKRHTPLSKLMKAYCERQGLSM 55
SUMO3 MADE  KP KE  GVKTENNDHINLKVAGQDGSVVQFKIKRHTPLSKLMKAYCERQGLSM 56
*     **  *  * * *    * *** *** *   ** *  * * **   ** ***  *
N-terminal tail

 
61        71         81        91       101
|         |          |         |         |
SUMO1 NSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV 101       
SUMO2 RQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGGVPESSLAGHSF 103
SUMO3 RQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGGVY 95  
** * ** *    **  * ** ** * * * ****        
C-terminal tail C-terminal
peptide
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strands and a (-helix (fig 11b and 11c). Unlike Ubiquitin, SUMO proteins have long 
unfolded C- and N- termini (“tails”) in which most of the differences between the 
isoforms are concentrated.  
 All SUMO have in their C-terminal sequence two consecutive glycine residues 
(“Gly-Gly motif”) followed by a “C-terminal peptide” which is cut off at the beginning of 
the Sumoylation process (fig 11a).   
 SUMO2 and -3, but not SUMO1 have a Sumoylation site (i.e. they can be 
sumoylated at that place) in their N-terminal tail (fig 11a), allowing the formation of 
poly-SUMO chains. 
 SUMOylation has very various and numerous functions in many cellular 
processes (among other, transcription control, regulation of ubiquitinylation, 
transcription controls…). Those functions have been often reviewed over the last 
decade, and particularly well so by [Dohmen, 2004]. This section will therefore not 
detail those aspects and concentrate on the structural knowledge on SUMO, which 
has not yet been the subject of a dedicated review.  
 
3. The Sumoylation process  
 
Sumoylation is carried out by a machinery similar to that responsible for 
ubiquitinylation. It is a complex process involving four steps. Due to the effort of 
several research groups, we now have a good structural knowledge of those steps, 
which will be presented in the present section.  
The first step –removal of the amino acids following the Gly-Gly motif- is 
performed by several dedicated proteases. Each of those proteases is able to 
process any SUMO isoforms, albeit with very different affinities. In practice, each 
SUMO isoforms appears to be processed by a particular SUMO protease. Substrate 
recognition by SUMO proteases is exclusively based on the sequence of the C-
terminal peptide.  
Since the enzymes catalyzing the following step of Sumoylation specifically 
recognize a C-terminal Gly-Gly motif on SUMO as a substrate, it is essential that the 
removal of the C-terminal peptide takes place. Failure of the SUMO proteases to 
perform their function leads to absolute inhibition of Sumoylation.  
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Structures of the SUMO protease Senp2 alone (1THO) and in complex with SUMO1 
(1TGZ) have been solved [Reverter & Lima, 2004] have been solved. The latter 
structure is of a complex artificially blocked after the protease reaction has taken 
place, but with the Gly-Gly motif still in the active site. This structure shows why it is 
necessary for the function of the enzyme that Gly-Gly motif is present in C-terminal of 
SUMO: the “tunnel” leading to the active site is too narrow for any other amino acid to 
fit into it (Fig. 12). Since the C-terminal peptide is not present in this structure, we still 
have no structural information on the mechanism by which Senp2 recognizes SUMO 
isoforms. The contact surface of SUMO1 for Senp2 is shown in Fig. 13. 
In the second step of Sumoylation, SUMO is transferred to an E1 enzyme (in man, 
the Sae1/Sae2 complex). Sae2 adenylates the C-terminal Glycin of SUMO and then 
forms a thioester bond between this Glycine and a Cysteine of Sae2. The energy 
gained in the hydrolysis of the ATP is stored in the thioester bond to be finally used in 
the Sumoylation reaction. Structures of the Sae1/Sae2 complex alone and with 
SUMO1 (PDB entries 1Y8Q and 1Y8R respectively) have been published recently 
Fig. 12: Structure of the SUMO1-Senp2 complex. SUMO1 is in pink, Senp2 in light grey. The side chains of the active site 
residues are in CPK colors, and the two tryptophan residues forming the tunnel through which the Gly-Gly motif accesses 
the active site are in lime green.  
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[Lois & Lima, 2005] (fig. 14). It shows that though yeast Sae1 is essential for 
Sumoylation to take place, it has neither direct implication in the E1 reaction, nor 
direct interaction with SUMO. Its role is to hold Sae2 in its correct conformation. The 
Sae2 moiety performs all the tasks required for the E1 function. It is made of three 
domains: the Cysteine Domain, the Adenylation domain and the Ubl domain. They 
delimitate a wide cavity that receives the C-terminal face of SUMO.  SUMO’s C-
terminal tail extends in a crevice on the adenylation domain surface leading to the 
active site where the C-terminal glycine of SUMO contacts ATP. In the following 
intermediates, which are not represented in the published structure, the C-terminal 
Glycine is adenylated, and conformational rearrangements in the E1-SUMO complex 
bring it in proximity of an active Cysteine in the Cysteine domain, to which it becomes 
bound through a thioester bond. The Ubl domain recruits the E2 enzyme Ubc9 for the 
following Sumoylation step, but no structural data is available on this interaction. The 
contact surface of SUMO1 for Sae1/Sae2 is shown in Fig. 15.  
 In the third step of Sumoylation, SUMO is released from Sae2 and its C-
terminal Glycine forms a Thioester bond with a Cysteine of the E2 enzyme Ubc9. 
Ubc9 also recruits the target protein. Several structural studies have investigated this 
  
Fig. 13: Interaction surfacor Senp2 on SUMO1. a) Structure of SUMO1 with the same color convention as on fig. 2. b) 
Structure of SUMO1 with the same orientation as in a), amino acids contacting Senp2  are in pink. C) Surface 
representation of SUMO1, amino acids contacting Senp2 are in pink, the orientation is the same than in a) and b). Amino 
acids of a protein are considered to contact another protein when at least one of their atoms is less than 7 away from an 
atom of that protein. The program Protein Explorer was used to find such contacts in all the protein complexes presented in 
this and the following figures.   
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step. The Structure of Ubc9 (1U9A) has first been solved by [Tong et al, 1997]. The 
interactions between SUMO and Ubc9 have been studied by NMR [Liu et al, 1999; 
 
Fig. 14: Sae1/Sae2-SUMO1 complex viewed from two different points (a and b). SUMO1 is in pink. Sae1 is in grey. Sae2 
domains are colored in different colors: the Ubiquitin-like domain is in blue, the adenylation domain in green and the Cystein 
domain in yellow. The position of the cystein to which the C-terminal Glycin of SUMO becomes attached is colored in red (in 
the present structure, it has been mutated to an alanine). The ATP molecule is in balls and sticks and CPK colors.  
 
  
Fig. 15: Interaction surface for Sae1/Sae2 on SUMO1. a) Structure of SUMO1 with the same color convention as in fig. 2. b) 
Structure of SUMO1 with the same orientation as in a), amino acids contacting Sae2 are in pink. c) Surface representation 
of SUMO1, amino acids contacting Sae2 are in pink, orientation is the same as in the previous panels.  
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Tatham et al, 2003]. Those works show that SUMO contacts Ubc9 through its β-
sheet, which offers a wide negatively charged interface [Bayer et al, 1998] (fig. 16). 
This surface contacts the area of Ubc9 surface defined by its N-terminal α-helix and 
first β-strand (fig. 17). This contact is important for the formation of the thioester 
bound SUMO1-Ubc9 complex, but once this complex is formed, it appears to be non 
essential for the Sumoylation reaction [Tatham et al, 2003]. The opposite face of 
Ubc9 recruits the target protein (fig. 17). The Ubc9-target interface on Ubc9 has been 
observed for Ubc9 interactions with p53 and c-Jun [Lin et al, 2002] and RanGap1 
[Bernier-Villamor et al,  2002]. The structural determinants that cause the target to be 
recognized by Ubc9 are not identified. The active site of Ubc9 is placed between the 
binding sites for SUMO and the target protein. The target lysine and the C-terminal 
tail of SUMO extend over the surface of Ubc9 to reach it (fig. 17).  
 The fourth step of Sumoylation is the Sumoylation reaction itself. It is calalysed 
by Ubc9 and an E3 enzyme. In contrast to the other Sumoylation enzymes seen 
previously, E3 enzymes are neither unique (at least four are known: PIAS3, PIASxα, 
 

Fig. 16: Interaction surface for Ubc9 on SUMO1. a) Structure of SUMO1 with the same color convention as in fig. 2. b) 
Structure of SUMO1 with the same orientation as in a), amino acids contacting Ubc9 are in pink. c) Surface representation 
of SUMO1, amino acids contacting Ubc9 are in pink, orientation is the same as in the previous panels.  
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RanBP2 and TOPORS) nor essential for the Sumoylation to take place. The role of 
the E3 enzyme is generally regarded as merely structural: it should maintain SUMO 
and Ubc9 in a favorable relative orientation  but does not make any covalent bond 
with SUMO or the target protein (the Sae1 protein discussed earlier in this section 
has a similar role).  Recent studies have shed some light on the structural aspects of 
the interactions between SUMO1 and PIAS [Song et al, 2004] and SUMO1 and 
RanBP2 [Reverter & Lima, 2005]. The later shows that RanBP2 a few amino acids of 
RanBP2 form an intermolecular β-sheet along the 2nd β-strand of SUMO1. The 
former shows that PIAS interacts with a region centered on the same β-strand of 
SUMO1.  The interaction surface of Ubc9 for RanBP2 has been found by [Tatham et 
al, 2005] to be the face of Ubc9 β-sheet opposite to its active site.  
 
4. Interactions of SUMO with other proteins 
 
As we have seen in the previous section, most of the SUMO interactions 
involved in Sumoylation are well known. The same is not true for the interactions 
between SUMO and proteins that do not take part in The Sumoylation process. 
Gly97 Lys524
Cys93
Fig. 17: The final Sumoylation complex. SUMO1 is in pink, RanGap1, the target protein, in blue, Ubc9 in grey and RanBP2, 
the E3 protein, in yellow. The side chain of the catalytic cystein (residue 93) of Ubc9 is in lime green, the side chains of 
Glycine 97 of SUMO1 and of the target lysine 524 of RanGap1 are represented in CPK colors.  
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Those proteins can be divided into two classes: target proteins and non-target 
proteins. A better knowledge of those interactions is essential to understand how 
SUMO proteins do function.  
There has been long discussion on whether SUMO functions as a mere tag 
that recruit some interaction partners that the unsumoylated target protein couldn’t 
recruit; by inducing structural changes in the target protein; or by preventing access 
to some part of the target protein’s surface. The past monthes have seen the 
publication of three structures examplifying each of those three possibilities. The two 
latter used to be the most popular, until a recent study on Sumoylated RanGap1 [mac 
Auley et al, 2004] showed that there are no interactions between the SUMO and  

  
Fig. 18 : Structure of Sumoylated Thymine 
DNA Glycosylase (TDG). a) Ribbon 
representation of the whole structure. SUMO1 
is in pink, TDG in grey, the target Lysine and 
SUMO1 C-terminal Glycine are in balls & sticks 
and CPK colors. Note the intermolecular β-
sheet between SUMO and TDG. b) ribbon 
representation of the SUMO moiety in the color 
scheme of fig. 2. The contact surface of 
SUMO1 for TDG is represented in ribbon (c) 
and surface (d) with the same orientation.    
a) 
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RanGap1 moieties in Sumoylated RanGap1: they simply behave like a tether. 
However, another study showed that target proteins do not always have such 
freedom toward their SUMO tag: the structure of Sumoylated Thymine DNA 
Glycosylase (TDG) (PDB entry 1WYW) [Baba et al, 2005] shows that both moieties 
are entangled through an intermolecular β-sheet (fig. 18). This structure allows to 
understand how Sumoylation is crucial for TDG to accomplish its function. No-
Sumoylated TDG binds to DNA and recognizes mismatched DNA nucleotides and 
excises a base from the mismatched pair. This results in conformational changes in 
TDG that cause it to clash with and release the bound DNA, letting the repair site free 
for an AP endonuclease which performs the following step in the repair process.  
 The structure of the Ubiquitin E2 enzyme E2-25K published by [Pichler et al, 
2005] (fig. 19) show that SUMOylation of the N-terminus of this protein does not 
substancially modify its structure. Instead, the SUMOylation site of E2-25K is placed 
in its E1  binding site. Thus, the SUMO moiety of SUMOylated E2-25K plays its  
Fig. 19: Structure of Sumoylated E2-25K. a) Ribbon representation of the whole structure. SUMO1 is in pink, E2-25K in light 
grey, the target Lysine and SUMO1 C-terminal Glycine are in balls & sticks and CPK colors. b) ribbon representation of the 
SUMO moiety in the color scheme of fig. 2. The contact surface of SUMO1 E2-25K is represented in ribbon (c) and surface 
(d) with the same orientation.  
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inhibitory role by hindering the access of the E1 enzyme to its binding site on E2-25K.  
If little is known on the structural basis of the interactions between SUMO and 
their target proteins, even less has been described on the interactions between 
SUMO other proteins. An interaction surface on SUMO1 for a PIASxα derived peptide 
has been determined by [Song et al, 2004]: it consists in amino acids of the second 
β-strand and the consecutive α-helix. However, the question of how the selectivity 
between the SUMO isoforms is achieved remains open: have some proteins more 
affinity for a particular SUMO isoform, and if so, what are the structural determinants 
for this selectivity? The present work is part of a cooperation project aiming at 
answering those questions by biochemical and biophysical means.  
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III) Identification of a SUMO-interacting motif in non-target proteins   
 
1. Molecular biology of SUMO interactions  
 
 Several studies have been dedicated to the definition of a “SUMO 
interactome” [Hannisch et al, 2005, Song et al, 2004], and have concentrated on 
identifying proteins interacting with SUMO1. The present work is part of a project 
aimed at comparing the interactions with the different SUMO isoforms. Since the 
results of the biochemical experiments made in this project are the basis of the work 
presented in this thesis, they will be presented shortly in this section.  
 Yeast Two Hybrids experiments were used to determine proteins binding to 
SUMO1 or 2. In those experiments, SUMO isoforms lacking the C-terminal Gly-Gly 
motif were fused to the Gal4 DNA binding domain of YTH9 and used as bait. The 
deletion of the Gly-Gly motif prevents the bait SUMO from being covalently attached 
to target proteins, ensuring that only proteins directly interacting with SUMO can be 
identified by those experiments. As a prey, cDNA banks from Spleen, Thymus and 
Kidney were used. The strength of the interaction between SUMO and the various 
preys was estimated by the intensity of the coloration obtained in X-Gal test. 21 
SUMO interacting proteins could be identified, 10 of which had not been identified as 
SUMO interacting proteins previously. With exception of previously identified 
Sumoylation proteins, the identified proteins all have functions involving DNA or RNA: 
transcription factors, helicases, repair enzymes, etc… Most of those interact equally 
well with SUMO1 and 2. Some, however, showed preference for either isoform. 
Those results were confirmed by GST Pulldown experiments.  
In most cases, the SUMO interacting motifs identified in previous studies could 
be identified in the proteins retrieved from the Yeast Two Hybrid experiments. 
However, this was not the case for three of them (namely TTRAP, MCAF and 
ZCCHC12). TTRAP was selected as representative from those three proteins. It 
could be shown by GST pulldown experiments that exclusively the C-terminal part of 
TTRAP has ability to bind SUMO. It contains the sequence at Ile-Val-Asp-Val 
positions 280 to 284, which corresponds to the SUMO interacting motif defined by 
[Song et al, 2004] read backwards. To confirm that those amino acids are indeed 
responsible for binding to SUMO, half or all of them were mutated to alanine. The 
resulting mutant had very limited or inexistent capacity of binding to SUMO, 
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confirming the essential role of the Ile-Val-Asp-Val tetrapeptide of TTRAP in SUMO 
binding.  
  Bioinformatic analysis of the sequence of the identified SUMO interacting 
proteins enabled to define a SUMO Interacting Motif (SIM). It consists of a 
hydrophobic core made of 3 Isoleucines or valines and another amino acid preceded 
or followed by a negatively charged tract of around 15 amino acids. In most cases, 
several serines are found between the hydrophobic core and the negative tract. 
Those serines, as will be discussed later, are a phosphorylation site. Thus, this new 
definition of the SIM is also a synthesis of the elements formerly shown to be 
important for SUMO binding.   
 
2. Aim of the present studies  
 
Having defined a short motif responsible for SUMO binding in a large number 
of proteins clamored for understanding the modalities of this binding and the 
mechanism by which SUMO isoform specificity can be achieved by the different SIM 
despite their strong overall similarity. The aim of the present work is to provide 
structural understanding for the binding of the SIM to SUMO1 and SUMO2 and the 
ways SUMO isoforms specificity is achieved: what kind of contacts between the SIM 
and SUMO are involved, and what are the roles of the different elements of the SIM, 
and how the SIM discriminates between different SUMO isoforms. Since it allows 
observation of the behavior of single atoms in a molecule in solution, NMR was 
chosen as the method to observe the effect of the binding of peptides containing all 
or parts of the SIM of PIAS and TTRAP on each individual amino acids of SUMO.  
 
 
 
 
Materials & Methods 
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1. Cloning, Protein expression and purification for NMR studies 
 
Full length SUMO1 and SUMO2 –preceded by a thrombin cutting site- were cloned 
as GST-fusions into pET-41a vectors (Novagen). The original thrombin cutting site of 
this vector was mutated using the QuickChange mutagenesis kit (Stratagene) from 
according to manufacturer’s instructions with the following primers pET41 delete 
THRB fwd (cg ggt ctg gtg cca GCC ggt agt act gca at) and pET41 delete THRB rev 
(at tgc agt act acc GGC tgg cac cag acc cg). The SUMO gene sequence was 
amplified from vectors containing the corresponding ESTs using the primers 
SUMO1_NcoI_Start (atatat ccatgg ga tta gtc cct agg gga agc   atg tct gac cag gag 
gc) and JO-211 (aaattt ggatcc atTA aac tgt tga atg acc ccc cg) for SUMO1; and 
SUMO2_NcoI_Start (tatat ccatgg ga tta gtc cct agg gga agc   atg tcc gag gag aag 
ccc). The PCR reactions were performed using the following protocol:  
  
Mix together  
10 u Taq DNA polymerase  
5 µL Buffer 
1,6 µL each primer (from a 10pmol.µL-1 solution) 
4 µL dNTP (from a solution containing 2,5 mM of each nucleotide) 
35,4 µL water 
2 µL template (vector at 100 ng.µL-1) 
The PCR program is: {[95°C, 1’], 26{[95°C, 30’’], [45°C, 45’’], [72°C, 2’]}, 
[72°C, 10’], [4°C, ] } 
  
The PCR products and host pET41a vectors were digested with the restrictions 
enzymes NcoI and BamHI:  
  
Add to 50 µL DNA to be digested (either the product of a PCR reaction or 100 
ng.µL-1 vector solution) 
10 u NcoI  
20 u BamHI 
6,5 µL BSA (from a 1 µg.µL-1 solution) 
6,5 µL BamHI buffer from New England Biolabs 
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 Incubate at 37°C for several hours 
  
The digested vector was purified on a 1,2% agarose gel and extracted from it using 
QiaQuick (Qiagene) columns according to manufacturers instructions. The digested 
PCR products were purified using miniprep columns (Qiagene) according to 
manufacturer’s instructions to a final volume of 50 µL. The PCR product and the 
vector were then ligated:  
 
Mix  
1,5 µL T4 DNA ligase 
4,6 µL Ligase buffer 
8µL purified digested PCR product  
32 µL purified digested vector 
Incubate overnight at 16°C  
 
The ligation product was introduced in E. coli Rosetta cells by heat shock technique:  
 
5µL of ligation reaction are added to an aliquote of chemically competent cells 
which are then placed on ice for 20-40 minutes, heated at 42°C for 45 seconds 
in a water bad and cooled on ice. 400 µL of LB medium without antibiotics are 
added to the cells which are agitated at 37°C for 1 hour and then plated on LB-
Kan plates and grown overnight. Single colonies were picked for further 
culture.  
 
The constructs were checked by sequencing (in house, using the BigDye terminator 
system from AbiPrism). The constructs were expressed in E. coli Rosetta cells on 
either LB or 2YT medium (for non marked protein), or minimal medium with 15NH4Cl 
and 13C6-Glucose for production of 15N and 15N +13C labeled protein. Cultures were 
grown in 3L flasks (~1.5 L culture per flask) at 37°C under agitation (100-120 rpm). 
Growth was monitored by following the optical density at 600 nm (“OD600”) of culture 
probes. When the culture reached OD600~0.8, the culture were induced by addition of 
1mM IPTG and further cultivated for 6-10 hours.  Cells were harvested by 
centrifugation, resuspended in PBS buffer and sonicated. The cell debris were 
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pelleted by ultracentrifugation (17000 rpm in a SS-34 rotor) and the recombinant 
protein was purified from the supernatant on GSH resin (Amersham) according to the 
manufacturer´s instruction. The purified fusion protein was cleaved with thrombin (5 
units per liter of cell culture) for 4 hours at room temperature, leaving the extension 
Gly-Ser in N-term of the full length SUMO, 30 and 5 KDa cutoff concentrators 
(Amicon) were used for tag removal and concentration.  Purity was checked visually 
on SDS-PAGE gels. The absence of many unaccounted for peaks on the HSQC 
spectra was a further proof of the purity of the obtained protein. MALDI mass 
spectrometry was used to check the integrity of the obtained SUMO. The obtained 
protein was lyophilysed and stored at -20°C.  
 
2. NMR Spectra acquisition and assignment 
 
All measurements were made at 27°C in 25mM Phosphate buffer (Natrium salt) at 
pH 7. Triple resonance and 2D experiments were performed on a Varian Inova 600 
equipped with shielded Z gradients. The water resonance was suppressed using the 
WATERGATE sequence or by presaturation. Prior to Fourier transformation all 
spectra were multiplied by a cosine bell function. Generally 2048x256 data points 
were used for acquisition of HSQC spectra and 1024x12x80 for three dimensional 
edited spectra. 3D NMR spectra were processed using the standard Bruker software 
XWINNMR. 2D NMR spectra were processed using NMRpipe (Delaglio et al., 1995) 
(relevants parameters are listed in the fid.com and ft2.com scripts bellow). Analysis 
and visual representation of two-dimensional spectra were performed using Sparky 
(Goddard T.D. and Kneller D.G.) and three-dimensional spectra were analyzed with 
the program Aurelia (Bruker) on O2 and Octane workstations (Silicon Graphics Inc.). 
Assignment of SUMO2 was generated using the spectra HNCA, HNCACB, 
CBCA(CO)NH, HC(CO)NH, C(CO)NH.  
 Scripts: 
Fid.com (transforms a spectrum in .fid format –the “Varian” format- to a 
spectrum in “nmrPipe format” which it stores in test.fid):  
#!/bin/csh 
 
var2pipe -in  
#the following line give the location of the input file  
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/work/rabiller/nmr/sumo2/spectra/SUMO2_PPIAS_2004_11_18/SUMO2_and
_50uL_PPIAS_2004_11_18.fid/fid   \ 
  -xN              1024  -yN               256  \ 
  -xT               512  -yT               128  \ 
  -xMODE        Complex  -yMODE        Complex  \ 
  -xSW         9000.900  -ySW         2200.000  \ 
  -xOBS         599.835  -yOBS          60.787  \ 
  -xCAR           4.754  -yCAR         114.125  \ 
  -xLAB              H1  -yLAB             N15  \ 
  -ndim               2  -aq2D          States  \ 
  -out test.fid -verb -ov 
 
sleep 5 
 
ft2com (performs the processing of the input spectrum –here test.fid- and 
stores the processed spectrum in test.ft2)  
 
#!/bin/csh -f 
 
# 
# Basic 2D Phase-Sensitive Processing: 
#   Cosine-Bells are used in both dimensions. 
#   Use of "ZF -auto" doubles size, then rounds to power of 2. 
#   Use of "FT -auto" chooses correct Transform mode. 
#   Imaginaries are deleted with "-di" in each dimension. 
#   Phase corrections should be inserted by hand. 
 
nmrPipe -in ./test.fid                       \ 
| nmrPipe  -fn SOL                                       \ 
| nmrPipe  -fn POLY -time -verb                  \ 
| nmrPipe  -fn MAC -macro $NMRTXT/ranceY.M -noRd -noWr        \ 
| nmrPipe  -fn SP -off 0.5 -end 0.95 -pow 2 -c 0.5      \ 
| nmrPipe  -fn ZF -auto                                       \ 
| nmrPipe  -fn ZF -zf 2                                 \ 
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| nmrPipe  -fn FT -auto                                       \ 
| nmrPipe  -fn PS -p0 -88 -p1 -25 -di -verb                 \ 
| nmrPipe  -fn EXT -x1 6.2ppm -xn 11.3ppm -sw -verb    \ 
#| nmrPipe  -fn EXT -x1 6.1ppm -xn 10.8ppm -sw -verb    \ 
#| nmrPipe  -fn EXT -x1 -0.4ppm -xn 6.0ppm -sw -verb    \ 
| nmrPipe  -fn TP                                             \ 
#| nmrPipe  -fn LP -ps0-0 -verb                      \ 
| nmrPipe  -fn SP -off 0.5 -end 0.95 -pow 2 -c 0.5           \ 
| nmrPipe  -fn ZF -auto                                       \ 
| nmrPipe  -fn ZF -zf 2                             \ 
#| nmrPipe  -fn ZF -size 32                          \ 
| nmrPipe  -fn FT -auto                                       \ 
| nmrPipe  -fn PS -p0 0 -p1 0 -di -verb                   \ 
#| nmrPipe  -fn REV                                             \ 
| nmrPipe  -fn TP                                             \ 
#| nmrPipe  -fn EXT -y1 5.4ppm -yn 10.5ppm -sw -verb    \ 
#| nmrPipe  -fn POLY -auto -verb                  \ 
#| nmrPipe  -fn POLY -auto -xn 4.72ppm -verb                  \ 
#| nmrPipe  -fn POLY -auto -x1 4.62ppm -verb                  \ 
   -ov -out ./test.ft2 
 
3. NMR titration experiments 
For peptide titration experiments HSQC spectra were performed on 15N labeled 
SUMO1 or 2 (300 mM in 25 mM Phosphate buffer pH7). Unlabeled peptide (Thermo 
Electron GmbH) were titrated to the protein to reach a final Peptide:SUMO ratio of 
1,36:1.    
KD values were measured by two different methods, depending on the exchange 
regime. For amino acids in fast exchange regime, at each titration step, the distance 
of each peak from its original position was measured using the normalization 
proposed by (Ayed et al., 2001) The obtained curves were fitted to a Hill-4-
parameters model using the software SigmaPlot. For amino acids in slow exchange 
regime, we estimated ke=1(kex/kon), where kex is the inverse of the lifetime of the 
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protein-peptide complex. In the case of slow exchange, the system is diffusion 
limited, giving kon~108 M.s-1, and kex<pi∆υ/√2, ∆υ being the chemical shift difference 
in Hertz between the resonance without peptide and the resonance in saturated 
conditions for the considered atom. Therefore, ke ~2.22 10-5 ∆υ in the case of slow 
exchange.  
 
4. Tryptic digestion of PIAS and detection of the resulting fragments by MALDI 
spectrometry 
 
HEK 293T cells were transfected with Flag-PIAS, lysed and the Flag-PIAS 
expression was checked with Western blot analysis as described before (Haglund et 
al). Immunoprecipitation of Flag-PIAS was done with M2-agarose from Sigma 
according to manual instruction. Immunoprecipitated PIAS was loaded on SDS-
PAGE gel and stained with Coomassie (this part of the work was performed by 
Christina Hecker). 
The band containing PIAS was cut out of the gel and transferred into a microtube. As 
a negative control, a same sized bit of the gel cut from a region containing no protein 
and further handled as the probe. Except the digestion itself, all further steps were 
performed at room temperature under agitation (1000 rpm). The band was destained 
overnight using 0.5 mL of Acetic Acid/Methanol/Water 1:2:7 (V:V:V). It was washed 
for 4 hours with water, dried in Speed Vac, washed with (50% Acetonitrile 50% 0.2 M 
NH4 HCO3 in water, pH8.9) and dried in Speed Vac again. The band was soaked 
with 15 µL of 0.2 M NH4 HCO3 in water, pH 8.9 containing 33 micrograms.mL-1 
trypsin proteomic grade (Sigma). The gel was reduced into little bits using the heat-
rounded tip of a pasteur pipette and incubated at 37°C for 24 hours. The bits were 
washed with water for 2 hours, dried in speed vac, and covered with 50 microliters of 
formic Acid/Water/Isopropanol 1:3:2 (V:V:V) saturated with alpha-Cyano-4-
hydroxycinnamic acid (CHCA). After overnight incubation, tubes were opened to 
allow crytallisation of the CHCA together with the extracted peptides. The obtained 
solution was pipetted onto the MALDI plate avoiding to pipette gel bits. 
Measurements were made in reflector positive mode, low mass gate set at 500 Da, 
and monitoring the 1 Kda-3KDa range. 
 
 
 
 
 
Results 
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 1. The SIM contains a phosphorylation site  
 Most of the SIM identified in the proteins obtained by Yeast Two Hybrids 
experiments contain several successive serines and occasional threonines between 
their hydrophobic core and negatively charged tract. As this looks typical of 
phosphorylation sites, the phosphorylation of SIM was investigated by bioinformatics 
and experimentally.  
The program NetPhos [Blom et al, 1999; www.cbs.dtu.dk/services/NetPhos] 
was used on the different SIM, nearly all of which were predicted to contain at least 
one phosphorylation site with a probability higher than 90%. The recurrence of this 
prediction for all SIM makes it very unlikely that it is a false positive result. 
Phosphorylation can therefore be viewed as a constitutive characteristic of SIMs.  
To experimentally verify the phosphorylation state of the SIM of PIAS, MALDI 
fingerprinting experiments were made on PIAS produced in mammalian cells (see 
Material & Methods section 4). Immunoprecipitated and SDS-PAGE purified PIAS 
given by Christina Hecker was trypsin digested in the gel and extracted with a 
water/acetic acid/ethanol mix. The particularity of this protocol is that the peptides are 
extracted from the gel directly by the MALDI-matrix solution, yielding much better 
result than the standard procedure [ref] used in the first place. Analysis of the MALDI 
spectra obtained for the extracts showed low intensity peaks at masses expected for 
the Tryptic peptides containing the SIM with and without phosphorylation (table 2). 
Such peaks could not be found in the negative control (empty gel piece handled the 
same way as the PIAS-containing gel bands). This shows that at least a fraction of 
PIAS is phosphorylated in vivo, but doesn’t give any information on which of the three 
phosphorylable serines is actually phosphorylated.  
 
2. Structure of the SUMO Interacting Motif  
 As described in the introduction, the SUMO interacting motif (SIM) appears to 
be limited to a peptide less than 25 amino acids in length within the proteins. This 
small size makes it doubtful that the SIM be a domain of its own right. One may ask 
whether the SIM is completed by further features in the three dimensional structures 
of the proteins containing it.  
 Models of the three dimensional structure of the proteins retrieved from the 
Yeast Two Hybrids experiments were produced using the program 3D-PSSM [Kelley 
et al, 1999].  
 
 
 
-
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Table 2: Peptides corresponding to the SIM of PIAS detected by MALDI fingerprinting on immunoprecipitated PIAS from mammalian cells (HEK 293T). The position of these peptides in PIAS 
sequence is given in the second column, their expected mass with and without phosphorylation in the third and fourth column. Since the signal was very weak, only masses with which two 
isotopic masses could be associated were retained. The mass measured for the peptide with no, one or two isotopes are refered to as m, m+1 and m+2. The annotations “well62_b_003” refer 
to the well on the MALDI plat in which the measurement was made, and the serial number of the measurement.  
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No constant three dimensional elements could be distinguished in those models. In 
all cases, the SIM is found in unstructured regions outside the core of those proteins. 
The core of the SIM and the amino acids surrounding it have a composition 
characteristic of β-strand but are often in a position that makes it unlikely for them to 
be part in a β-sheet of the protein. The rest of the SIM can be in all cases predicted to 
adopt random coil conformation. The SIM is therefore likely to be the sole element 
responsible for SUMO binding. Its short size and lack of tertiary structure make it a 
perfect candidate for peptide binding studies: instead of investigating the binding of a 
whole protein to SUMO, which brings about all difficulties associated with high 
concentrations of a protein in solution, one can observe the binding of a short peptide 
derived from its SIM to SUMO and obtain relevant results.  
 
3. Design of PIAS- and TTRAP derived peptides  
 
 In this study, peptides derived from the SIM of PIAS (SwissProt entry O75928) 
and TTRAP (SwissProt entry O95551) were used. The sequences and features of 
those peptides are presented on fig. 20. PIAS_long contains all of the SIM of PIAS. 
PPIAS has the same sequence as PIAS_long and is phosphorylated on serine 476, 
which is the most probably phosphorylated serine in PIAS. PIAS_short contains the 
hydrophobic core of the SIM and a few amino acids around it, but lacks the 
negatively charged tract. TTRAP derived peptides were designed referring to the 
IVDVWEFLGK
GGLPNNIVDV
DTNLRDREVTRCGGLPNNIVDVW
KVDVIDLTIESSSDEEEDPPAKR
KVDVIDLTIESSSDEEEDPPAKR
VDVIDLTIES
TTRAP_short_Cside
TTRAP_short_Nside
TTRAP_long
PIAS_long
PPIAS
PIAS_short

Fig. 20: Peptides used in this study. The hydrophobic core is highlighted in yellow. Positively 
charged amino acids are in blue, amino acids bearing a negative charge in red. Phosphate groups 
are symbolized by a circled “P” above the amino acids bearing them. 
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PIAS derived peptides. The four amino acids making the hydrophobic core of 
TTRAP’s SIM are the same as in PIAS, but in inverted order. In absence of a clear 
negatively charged tract to give an orientation the TTRAP_long peptide was therefore 
designed as the hydrophobic core of the SIM and enough amino acids in N-term of it 
to have the same length as PIAS_long (in PIAS_long, the rest of the amino acids are 
in C-term of the hydrophobic core). Two further TTRAP derived peptides were 
designed to be comparable to PIAS_short: TTRAP_short_C-side and 
TTRAP_short_N-side. Both are the same length as TTRAP and contain the 
hydrophobic core plus a few amino acids in C-term of it (like in PIAS_short) or in N-
term of it (orientation oppose to that of PIAS_short). Since no phosphorylation site 
can be found in TTRAP’s SIM, no phosphorylated TTRAP peptide was designed. All 
those peptides were ordered in highly purified form from the company Thermo 
Electron GmBH.  
 
4. Cloning and protein production  
 This study required large quantities of variously isotope-marked full length 
SUMO1 and SUMO2. It was therefore chosen to produce the needed SUMO as 
recombinant protein in the Escherichia Coli bacteria optimized for protein production. 
To simplify the purification process and guarantee high purity and yield, it was 
chosen to produce SUMO in a GST fused form. To reduce the complexity of the NMR 
spectra as much as possible and avoid interferences of the GST tag, this tag had to 
be removed leaving as few exogenous amino acids as possible on SUMO. In 
prevision of further studies, SUMO3 and –4 were cloned as well. The experimental 
procedures followed for cloning and protein purification are described in the section 1 
of the Materials & Methods part.  
 The pET41a vector from Novagen was selected for cloning of SUMO. It 
contains an endogenous Thrombin cutting site to be used for tag removal. However, 
this site is several amino acids away from the closest recombinant protein insertion 
site. It was therefore mutated to prevent thrombin cleavage and a new thrombin 
cutting site was introduced immediately in N-term of SUMO (fig. 21) in the cloning 
process.   
ESTs containing the mRNA sequence of SUMO1, -2 and -3 were purchased 
from Invitrogene. The SUMO sequences to be cloned were amplified by PCR from 
those ESTs using primers bearing restriction sites (for cloning into the vector) and, in 
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the case of the forward primer, the sequence of a thrombin cutting site. The 
correctness of the SUMO sequence and their insertion in the vector was checked by 
sequencing. SUMO1, -2, -3 clones were produced. 
 
A different route was 
chosen for cloning SUMO4. 
No EST was available for this 
gene, but fortunately 
SUMO4’s gene contains no 
exons, meaning that its 
translated sequence can be 
obtained by amplifying 
genomic DNA without any 
further processing. To this 
purpose, a commercial kit 
(Sigma) was used to extract 
Leu Val Pro Arg Gly Ser SUMO
NcoI BamHI
thrombin
Forward primer Reverse primer
Fig. 21: Cloning of SUMO into the multiple cloning site of the pET41a vector. The original thrombin cutting site coded by 
the vector (boxed) is first mutated to prevent thrombin digestion at this site in the recombinant protein. A synthetic DNA 
construct coding for a thrombin cutting site directly followed by full-length SUMO  between a NcoI and a BamHI restriction 
sites is inserted in the pET41a vector. The extent of the primers used for it synthesis it is represented under the scheme 
the inserted construct.  
0
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Fig. 22: Typical evolution of a Rosetta cell culture used for SUMO 
production. In this particular case, The cells produce SUMO1, and are 
grown on 15N labeled minimal medium. The culture was induced after 560 
minutes by addition of 1mM IPTG. The last point (1080 min) is the 
measurement made just before harvest. A sample of the culture was 
reserved before induction and cultivated without IPTG. At harvest time, its 
OD600 was 3.4. OD values higher than 1 were calculated from values 
measured on diluted culture samples. 
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genomic DNA from the experimentator’s hair roots. SUMO4 gene sequence was 
amplified from this genomic DNA by PCR and cloned in the same way as the other 
three SUMO isoforms.  Sequencing showed that no clone without nonsense mutation 
was obtained. At that point, it turned out that it is doubtful that SUMO4 is a genuine 
gene, and no further work on SUMO4 cloning was made.  
Rosetta cells (Novagen) were transformed with the obtained pET41a vectors 
containing SUMO1 and SUMO2 and grown on 2YT medium (for obtention of plain 
protein) or on minimal medium with appropriately labeled Glucose and NH4 as sole 
source of Carbon and Nitrogen respectively (for obtention of 15N and/or 13C labeled 
protein). The bacteria were allowed to grow until they reached an optical density at 
600nm of around 0.8. At that point, 1 mM IPTG was added to the culture to induce 
the bacteria to produce the recombinant protein, and the bacteria were further 
incubated for 6-10 hours (fig. 22), harvested by centrifugation and lysed by 
sonication. The SUMO-GST fusion protein was then purified on a GSH column, 
eluted and treated with thrombin (alternatively, the thrombin cut was performed on 
His8GST
SUMO
30 kDa
centricon
5 kDa
centricon
Centrifugation
transfer of the 
flow through 
into a 5 kDa
centricon and 
Centrifugation
1 2 3 4 5 6 7 8 9 10 11 12 13
X→
Y→
21.5
14.4
31
36.5
Fig. 23: a) Use of centricons to separate 
SUMO from the GST-Tag and concentrate it 
after purification and Throbin cutting of the 
fusion protein. b) Coomasie gel with probes 
taken at different steps of  SUMO1 
production. Whole bacteria before induction 
(1), at harvest  without  (2) and with (3) 
induction, Pellet (4) and supernatant from 
centrifugation of the cell lysate. Flow 
Through (6), wash (7), thrombin cut (8), 
elute (9)  and clean (10) fraction from the 
GSH purification (the thrombin cut was 
made while the protein was still bound to 
the resin, the cut fraction contains the 
collected SUMO). The fractions retained by 
the 10 kDa  and 5 kDa centricons are in 
lane 11 and 12 respectively. Band X 
contains the fusion protein, Y contains 
SUMO 
a) 
b) 
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the column). Tag removal, concentration and setting in measurement buffer 
conditions were performed in a two-steps filtration (fig. 23a). In the first step, the 
thrombin-treated elute was passed through a 30kDa cutoff concentrator (”centricon”). 
This filter size is large enough to allow the GST-Tag free SUMO to go through, and 
small enough to retain GST and GST-SUMO fusion protein as well as thrombin and 
large molecular weight impurities. In the second step, the flow through of the first step 
was passed through a 10 kDa concentrator. This filter size is small enough to retain 
SUMO, but not the GSH. This allows concentration of SUMO and, by repeated cycles 
of dilution in the measurement buffer and subsequent concentration, to set SUMO in 
the measurement conditions without having to perform any dialysis step. Coomassie-
stained SDS page gels show with probes taken at the different steps of the protein 
production and purification show that SUMO pure as far as it can be determined from 
this method (i.e. purity is higher than 90%).  
 
5. Assignment of the resonances of SUMO2 atoms  
 
 To investigate the effect of peptide binding on specific atoms of a protein by 
NMR, one needs to know the resonance frequencies of each of those atoms. For this 
purpose, a set of 3D NMR spectra of 15N/13C labeled SUMO2 was recorded. (see 
M&M 2.) The assignment was based on the HNCACB spectrum, following the chain 
tracing procedure described in the introduction. The program PaarFind (Karl-Heinz 
Müller, not published), which is able to pick peaks and identify the most obvious 
sequences of peaks quartets was used for a first approach of the HNCACB 
spectrum, its output being manually checked, assigned and completed. In order to 
calculate a high resolution structure of SUMO2, the resonances of a number of the 
backbone and the side chain atoms were assigned using the other 3D spectra. The 
publication of a crystal structure of human SUMO2 [Huang et al, 2004] made the 
structure calculation superfluous, and no further step was taken in this direction. The 
assigned HSQC spectrum of SUMO2 is shown in fig. 24. As several assignments of 
SUMO1 have already been published [Jin et al., 2001; mac Auley et al., 2004, by far 
the most helpful being the one published by mac Auley et al], it was not necessary to 
produce a new one.  
 In general, atoms do not have exactly the same resonance frequencies in 
different spectra. Those differences are generally small, but can cause some 
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difficulties in assigning the resonances in one spectrum using the frequencies found 
in another one. To simplify the assignment of HSQC spectra using values from the 
HNCACB spectrum or obtained from literature, a graphic representation of the 1H and 
15N resonances obtained from the 3D spectra spectrum was produced with the 
program SigmaPlot and overlaid on the actual HSQC spectra. This allows seeing at 
one glance all expected and measured peak, which is of great help for sorting out the 
assignment ambiguities.  
 
6. Measuring  the effect of the binding of a peptide on all amino acids of a protein 
 
As exposed in the introduction, the binding of a ligand modifies the 
electromagnetic environment of the atoms of a protein, especially of those in the 
neighborhood of the binding site. This results in modifications of the resonance of 
those atoms in NMR. Those modifications can be observed by taking a series of 
Fig. 24: Assigned HSQC spectrum of SUMO2.  
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NMR spectra in the course of the titration and observing the evolution of the 
resonances of interest. This method, originally -and in most cases incorrectly- known 
as “SAR by NMR” has become very popular since its publication by [Shuker et al, 
1996] and is used with HSQC spectra which have the advantage of being quickly 
measured and reflect the behavior of the backbone of the protein.   
For the peptide titration experiments used in this study, a 1.35-fold molar 
excess of peptide was added in 10 steps to a 0.3mM SUMO solution and a HSQC 
spectrum was recorded after each addition. In the overlay of those spectra, peaks are 
observed to have different behaviors. Some are constant, other gradually change 
position, disappear and then reappear at a new position, or simply disappear (fig. 
25). This section will expose how this can be interpreted and how those spectra are 
analyzed to gain quantitative information on binding.  
The obviously simplest –and least informative- case is that of peaks that 
change neither in position nor intensity in the course of the titration. This visualizes 
that the resonances of the corresponding atoms stay constant in frequency and 
intensity, meaning that the environment of those atoms is not modified by the binding.  
K34
L44
Fig. 25: Effect of the peptide binding on HSQC peaks.  
Regions of HSQC spectra taken in the course of the 
titrations (see text) are overlaid. Peptide coloration I 
color coded from violet (no peptide) to red (maximal 
peptide concentration) over blue, green and yellow. Leu 
98 and Ala 99 of SUMO2 are not affected by the binding 
of the PIAS_short peptide. The corresponding peaks 
conserve their original intensity and position throughout 
the titration. Leu 44 of SUMO1 is in fast exchange 
regime with the PIAS_long peptide: its HSQC peak 
conserve its intensity but changes position in the course 
of the titration. Lys 34 of SUMO2 is in intermediate 
exchange with the PIAS_long peptide. Its HSQC peak 
changes position during the titration, and is intense only 
when the bound or free protein is largely majoritary.  
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In all other cases, the changes in position and/or intensity of HSQC peaks 
show that the corresponding atoms are affected by the binding. This is the result of 
the atoms changing environment (“free protein” and “bound protein”) at different rates 
(“exchange rates”) when the ligand is added. This phenomenon is called “chemical 
exchange”. It gives access to information on the exchange rate (the frequency at 
which the spin changes environment) and therefore gives a possibility to calculate 
exchange constants (ke) for individual atoms in a protein. Exposing how this can be 
done will require a preliminary explanation on chemical exchange rates and their 
effects on peak shape and position.  
The prerequisite for observing an effect of chemical exchange on NMR 
resonance frequency and intensity is that the resonance frequency is in the order of 
magnitude of the exchange rate. This condition fulfilled, let us consider a spin moving 
between two different environments (it may be, for example, found in the side chain 
Fig. 26:  Resonances of spins changing environment at different rate. The upper part of the figure shows a Spin changing 
environment at a rate slower than the difference of frequency between the resonances in the two environments. As seen on 
the resulting FID on the left, the Spin has time to make several revolutions in each of the environments. Fourier 
transformation of this FID (upper right) gives two peaks, one for each of the resonance frequencies, weighted by the time 
spent by the Spin in each environment. The lower part of the figure shows the case of a Spin changing environment at a 
frequency much higher than the difference between its resonances frequencies in the two environments. In this case, the 
Spin has time to make only a small fraction of revolution in each environment, resulting in a FID that appears to have an 
average frequency, weighted by the time spent by the Spin in its two environments. Fourier ransformation of this FID (lower 
right) gives a single peak at the average frequency.  
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of an amino acid moving between a buried and a solvent-exposed conformation). In 
one of those environments, the spin will have a resonance frequency of 10 Hz, in the 
other one of 2Hz, the average lifetime of each state being 2s. This lifetime 
corresponds to an exchange rate of ½ s-1=0.5 Hz, which is significantly smaller than 
the difference between the resonance frequencies of the spin in its two environments 
(10-2=8Hz). Such a situation is called “slow exchange”. The FID curve obtained 
when making an NMR measurement on such a spin will be composed of segments 
with a frequency of 10 Hz and segments with a frequency of 2 Hz (fig. 26). The FID 
for a number of such spins would contain both frequencies -2 and 10 Hz- which 
would, by Fourier transformation, give two peaks, one at 2 Hz, the other at 10 Hz (fig. 
26). If for whatever reason (they have different lifetime, one environment is 
encountered more often than the other…) the two states are differently populated, 
the intensity of the corresponding peaks will be accordingly unequal.  
We have seen that if the exchange rate between the two environments of a spins is 
much smaller than the difference between its resonance frequencies in those two 
environments, one peak is observed at each of those frequencies in a NMR 
spectrum. What happens if the exchange rate is much higher than this frequency 
difference, a situation called “fast exchange”? In this case, the spin will be able to 
change many times of environment in the time it needs to complete a single 
revolution in either of those environments. This will result in a FID for a single spin 
made of very short segments of FIDs of both frequencies, which looks like a FID 
containing a single frequency –the average of the resonance frequencies in the two 
environments, in the present case (2+10)/2=6 Hz. By Fourier transformation of this 
FID, a single peak at 6 Hz (fig. 26) will be obtained. As before, this average is 
weighted if the to environments are unequally populated.  
If, finally, the exchange rate becomes of the same order than the difference 
between the resonance frequencies of a spin in its two environments –a situation 
called “intermediate exchange”, the corresponding NMR peaks will broaden and their 
position will move toward the average between the resonance frequencies in the two 
environments. The origin of this phenomenon is the dephasing arising at each 
transition between two resonance frequencies: each time a spin changes resonance 
frequency, it loses its original phase. In a population of spins, this results in a quickly 
decaying FID giving a broad NMR peak by Fourier transformation. It can be 
demonstrated that the maximum broadening is reached when the exchange rate is 
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equal to pi∆υ/√2, ∆υ being the difference between the resonance frequencies in the 
two environments. At this point, the NMR peaks corresponding to the two 
environments merge into a single one at the 
average between the resonances frequencies 
in those two environments. Fig. 27 shows an 
example of evolution of the NMR spectra 
obtained when varying the exchange constant 
between two environments of a group of 
identical spins.  
How does this relate to the behavior of 
NMR peaks in HSQC titrations?  
The peaks changing position but not 
intensity clearly correspond to spins in fast 
exchange as described above. At the beginning 
of the titration, no peptide has been added, and 
all the spins in a particular amide group are in 
“free protein” environment. As peptide is being 
added, more and more of it becomes bound to 
the protein, and accordingly more and more of the considered spins find themselves 
in a “bound protein” environment until saturation is reached and the bound 
environment prevails. At each step of the titration, the HSQC peak produced by those 
spins occupy a position corresponding to the average of the resonances frequencies 
in the “free protein environment” and the “bound protein environment” states, 
weighted by the respective populations of those states (fig. 27). The exchange 
constant (ke) associated with this behavior can be estimated as follows. Let Pf, Pb 
and Pt be the fractional concentration of free, bound ant total protein respectively. 
The peptide (L) binds to the protein (P) according to the simple balance equation  
 
 P+L→PL.  
 
The constant associated with this binding is  
 
 ke = [P][L]/[PL]  
 
ke
I
RF free bound
Fig. 27: Effect of the exchange constant ke on the 
NMR peaks produced by a group of Spins 
exchanging between two environments (here 
bound and free protein).  
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Since  
 
 [L] = [L]initial-[PL] 
 
the expression of ke becomes 
  
 ke = [P]  ([L]initial - [PL]) / [PL]  
 
which can be rearranged into ([Li] being the initial peptide concentration and [P]i the 
initial protein concentration):  
 
 ke  [PL] = [P]  ([L]i - [PL])  
 
 [Li] and [P]i are known –they are the 
concentration of peptide and protein 
introduced in the probe- and the position 
of the HSQC peak gives the rest of the 
information required to calculate ke. The 
position of a fast exchange peak in the 
course of the titration is the weighted 
average between its position in the 
absence of ligand and its position at 
saturation, when all protein is bound. Let 
∆max be the distance between the HSQC 
peak in free protein and in bound protein, 
and ∆if be the distance between the 
HSQC peak at an intermediate position and the HSQC peak in the free protein (fig. 
28, the normalization proposed by [Mulder et al, 1999] was used). We have  
 
 ∆if / ∆max = [PL]/([P]+[PL]) = [PL]/[P]i = y 
 
coming back to the expression of ke  [PL] and dividing both sides by [P]i:  
 
Fig. 28:  Overlay of the HSQC spectra taken in titration of 
SUMO2 with PPIAS. Only the peak corresponding to Lys41 
is shown. ∆max (distance between the bound and free 
protein peaks) is constant. ∆if (distance between the peaks 
for free protein and mixed bound and free protein) is 
different for each step of the titration. Here, ∆if after the first 
peptide addition (mauve peak) is shown.  
X
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 ke  [PL] /[P] i = [P]  ([L]i - [PL])/ [P] i 
 
Replacing [PL]/ [P]
 i by x, this becomes  
 
 ke  y = [P]  ([L]i / [P] i  - y) 
 
There is still a stray [P] –the actual free protein concentration- which can be replaced 
by [P]i - [PL], yielding  
 
 ke  y = ([P] i - [PL], ) ([L]i / [P] i  - y)  
 (ke  y)/ [P] i = (1 - y )  [L]i / [P] i  - y) 
 
This develops into 
 
 y² - y  (ke + [L]i + [P] i ) / [P]i + [L]i / [P] i  =0 
 
the solution of this quadratic equation is 
 
 y = ((ke + [L]i + [P] i) - ((ke + [L]i + [P] i)² - 4  [L]i  [P] i )) / (2  [P] i) 
 
Since ∆max is constant for each amino acid, y = ∆if / ∆max is always proportional to ∆if. 
Hence, by plotting ∆if against the total peptide concentration and fitting those points 
the equation above, the value of Ke can be calculated. However, in the present work, 
some titration curves did not follow expected the shape observed in SUMO2 titrations 
(fig. 29).  The Hill-4-parameters equation was therefore used to fit all data. This 
equation contains more parameters than the equation presented above, but is equal 
to it when those parameters are equal to zero. It is therefore perfectly suited for fitting 
titration curves that have the shape expected for a A+B→AB binding, and proved to 
fit the other data with very good correlation factors.  
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The case of peaks disappearing from one position to reappear at another 
position later in the titration is more delicate. Two possibilities can be envisaged: slow 
exchange or intermediate exchange. Let us examine what kind of peak behavior can 
be expected in either case.  
At the beginning of a titration with a ligand causing the observed spins to be in 
slow exchange, there is very little ligand present, and most of the protein is in the free 
state. consequently, the NMR peak corresponding to the free state is very intense 
whereas the one corresponding to the bound state is very small. This situation 
changes in the course of the titration. More and more ligand becoming available, the 
fraction of bound protein increases and the fraction of free protein decreases 
accordingly, which result in increasing intensity for the peak corresponding to bound 
state and decreasing intensity for the peak corresponding to free state (fig. 30). This 
looks like the behavior of the “disappearing-reappearing peaks”, with two significant 
differences: slow exchange peaks would not change position, and at least at some 
point of the titration, both should be visible simultaneously.  
Fig. 29: Comparison of binding curves typical of different titrations. Values obtained with Glu49 of SUMO1 and Met43 of 
SUMO2 are plotted. 
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At the beginning of a titration with a ligand causing the observed spins to be in 
intermediate exchange, there is very little ligand present, most of the protein is in the 
free state and a single peak is observed at the corresponding position. When more 
ligand is added, more and more of the spins have the opportunity to make incursions 
into the “bound protein” environment, which causes them to be out of phase with the 
rest of the spins. In consequence, the peak broadens and adopts a position 
intermediate between the “free protein” and “bound protein” positions. When the 
titration proceeds toward saturation, the “bound protein” environment becomes the 
most frequently occupied one, and incursions into the “free protein” environment 
become rarer. In consequence, the peak becomes sharper and its position becomes 
close to the “bound protein” position (fig. 30). This corresponds to the behavior of the 
experimental “disappearing-reappearing peaks”: the disappearance is caused by 
broadening which make the peak so broad and shallow that it is not detectable 
anymore. It can therefore be concluded that those peaks correspond to atoms in 
intermediate exchange. The value of the exchange rate (i.e. the rate at which the 
protein releases a bound ligand) Kex can therefore be estimated to be approximately 
equal to pi∆υ/√2 where ∆υ is the difference of resonance frequencies between the 
free and bound protein states. Furthermore, it can be assumed that the peptide-
I
RF free bound
I
RF free bound
Increasing ligand
concentration Fig. 30: Behavior of a NMR peak in slow exchange (left) and intermediate exchange (right) during a titration. The RF and I 
labels of the axes stand for “resonance frequency” and “intensity” 
respectively.  
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protein binding is limited by the diffusion rate. Kon, the rate at which the peptide 
contacts “encounter” the protein, is therefore of the order of 108 M.s-1. Having done 
those assumptions on Kex and Kon, it is possible to estimate the value of the 
exchange constant ke:  
 
  ke = Kex/Kon = pi∆υ/√2 / 108 = 2.2210-5∆υ 
 
This was used to estimate the ke of all atoms giving a peak that disappear in the 
course of a HSQC titration.  
 
7. Effect of binding to PIAS- and TTRAP derived peptides on SUMO1 and SUMO2  
 
 For the sake of comparability, all titration experiments in this study were 
conducted in the same way. A 1.35-fold molar excess of peptide was added in 10 
steps to a 0.3mM SUMO solution and a HSQC spectrum was recorded after each 
addition. The program Sparky [Goddard and Kneller] was used to overlay the spectra 
in order to visualize the behavior of the peaks in the course of the titration, and to 
determine the peaks position in each of those spectra. The peaks were assigned in 
each spectrum whenever possible (it happens regularly that two peaks adopt 
overlapping positions in the course of a titration, making it impossible to accurately 
determine the position of each).  
 In each titration, the initial spectrum, measured without peptide, was taken 
as a reference, and the distance of each peak in each of the spectra measured in the 
course of the titration to this original position (all in ppm) was measured using the 
normalization proposed by [Mulder et al, 1999]:  
 
  ∆δ = √(∆δHN² + (0.154 ⋅ ∆δN)²) 
 
where 0.154 is the scaling factor. The rationale for this normalization is the following. 
It is easily seen in any HSQC titration that upon ligand binding most peaks shift by a 
much greater number of ppm along the 15N axis than along the 1H axis. Part of the 
reason for this is the difference in the scale of the axes: 1ppm represents about 60 
MHz on the 15N axis and about 540 MHz along the 1H axis. Hence, if ligand binding 
or whatever environmental condition had the same effect on N and HN resonance 
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frequencies, a scaling factor of 60/540 ≈ 0.113 would have to be used when 
combining N and HN shifts expressed in ppm. Yet there is a priori no reason why the 
resonance frequencies of N and HN atoms should be affected exactly to the same 
extent by their environment, which would result in the average frequency shift in Hz 
along the 15N axis to be the same as the average frequency shift in Hz along the 1H 
axis. To have an accurate estimation of the relative effects of environment on 
frequency shifts of N and HN atoms, Mulder et al. calculated the variance of the 
chemical shifts of al N and HN reported in the BMRB database, and found the 
variance of N resonnance frequencies (in ppm) to be 0.154 time the variance of the 
HN resonance frequencies. Therefore 0.154 is used as a scaling factor to ensure that 
the effect of binding on both resonances is equally taken into account.  
 The exchange constants ke were calculated whenever possible for the single 
amino acids of SUMO in each titration using the methods exposed in the previous 
section. They are found to be in the low micromolar range for amino acids in 
intermediate exchange and in around 150 micromolar range for the vast majority of 
amino acids in fast exchange. For different reasons, the ke value couldn’t be 
estimated for some amino acids:  
- the peak for this amino acid could not be identified in the HSQC spectrum 
- the peak for this amino acid overlapped another peak making it impossible to 
determine its position 
- the peak for this amino acid changed position so little that fitting couldn’t be 
performed properly.  
- The amino acid was too far from saturation, making the calculation of ke 
imprecise.  
The obtained ke and ∆max values are represented in the tables 3 and 4 (for SUMO1 
and -2 respectively) and in graphic form (fig. 31 and 33) at the end of this section. 
Both representation of the results are linear, and do not take the three dimensional 
structure of SUMO into account. Yet a peptide binding site may consist of amino 
acids scattered along the sequence of SUMO but grouped together in its 3-
dimensional structure. This called for a representation of ke on the three dimensional 
structure of SUMO. Of course, writing its ke value next to every amino acid would be 
utterly illegible, and adding graphical elements to symbolize it would make the 
structure of SUMO unrecognizable. It was therefore chosen to represent ke values by 
a color coding. Using Yasara offers many advantages, but also imposes some 
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constraint on coloring possibilities: Yasara codes colors as an angle in degree 
corresponding to their position on a color wheel. It was therefore chosen to represent 
the range of ke values as a color range going from icy blue for high values of ke 
(corresponding to limited effect of peptide binding) to orange for low values of ke 
(corresponding to strong effect of peptide binding), over blue, violet, pink and red. 
The ke values calculated for amino acids in intermediate exchange being both 
imprecise and much smaller than those calculated for amino acids in fast exchange, 
they were all represented in yellow-green. ke values that could not be determined 
were color coded by grey. A procedure for defining the color coding for each amino 
acid in fast exchange had then to be defined. It was important that the values clearly 
standing out were represented by colors clearly standing out, and with the gradation 
seen in the graphical representation. This proved impossible to achieve using a 
simple linear gradient of color: in such a gradient, if the very lowest values of ke are 
represented in orange, all other values are represented in indistinguishable shades of 
another color. Therefore, a “square root gradient” was chosen, allowing the various 
low values of Ke to be clearly distinguished while the small variations of ke in the bulk 
of SUMO are not exaggerated.  
  Color code = int [410 + (Z  / |Z|)  √|Z|] 
where  
  Z = F  (ke - ke, ref ) 
F being a factor which value is chosen so that the obtained color range has the 
whished span. It must be clear that the color codes are specific to each titration, and 
a color does therefore not code for the same ke values in two different titrations.  
Structures of SUMO1 (PDB code 1A5R) and SUMO2 (PDB code 1WM2) colored 
according to this method are presented below (fig. 32 and 34 respectively).   
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Table 3: Ke (in mM) and ∆max (normalized ppm) values for the amino acids of SUMO1 in different titrations  
  SUMO1 PIAS_long SUMO1 PPIAS 
SUMO1 
PIAS_short 
SUMO1 
TTRAP_long 
Residue ke 
delta 
max ke 
delta 
max ke 
delta 
max ke class delta max 
S2 
            3 0.003004 
D3 
        0.1854 0.0034 3 0.004105 
Q4 0.2612 0.0266 0.1415 0.0528 0.2098 0.187 3 0.187031 
E5 0.1867 0.0134 0.0819 0.0114 0.2123 0.002 3 0.001848 
A6 0.2015 0.0033 0.0898 0.0028 0.1574 0.0021 3 0.002377 
K7 0.184 0.0147 0.11 0.0159 0.2136 0.0056 3 0.005176 
P8 
            3   
S9 0.193 0.0094 0.1142 0.0104 0.1582 0.003   0.002659 
T10 0.1901 0.024 0.1351 0.0331     2 0.008835 
E11 0.1954 0.0523 0.092 0.0426         
D12 
            2 0.00231 
L13 0.1816 0.0571 0.0989 0.0631 0.1895 0.0108 2 0.011654 
G14 0.1798 0.0365 0.1015 0.0424 0.2039 0.0123 2 0.012048 
D15 0.1715 0.0518         3 0.002941 
K16 0.1791 0.0507 0.0974 0.0572 0.1931 0.0099 2 0.009294 
K17 0.1134 0.006         3 0.002517 
E18 0.1861 0.0238 0.1068 0.0403 0.1866 0.0032 2 0.003672 
G19 0.1893 0.0606 0.1119 0.0674     3 0.004867 
E20 
            2   
Y21 0.1886 0.034 0.0924 0.0447         
I22 0.000003   0.000003   0.000003 0.0374 3 0.034084 
K23 0.1865 0.1019 0.1004 0.1433         
L24 0.0788 0.0395 0.12 0.0277     3   
K25 
        0.1988 0.0056 3 0.005552 
V26 0.1855 0.0676 0.1028 0.0664 0.1814 0.0042 3 0.002941 
I27 0.000003   0.000003   0.000003 0.0103 2 0.008599 
G28 0.1913 0.0374 0.1104 0.0301 0.1968 0.0074 1 0.007917 
Q29 0.1367 0.0157 0.0675 0.0144 0.2513 0.009 2 0.007605 
D30 0.1893 0.0512 0.1098 0.0559 0.1862 0.0054 3 0.004698 
S31 0.1869 0.0546 0.1027 0.0635     2 0.008094 
S32 0.1927 0.032 0.1081 0.0344 0.1712 0.0031 3 0.003532 
E33 0.1393 0.0369 0.0641 0.0382         
I34 0.1898 0.022 0.1258 0.029 0.2561 0.0026 2 0.002143 
H35 0.1912 0.0917 0.0984 0.0948 0.000003   0 0.007978 
F36 0.000003   0.000003   0.000003 0.0302 1 0.034574 
K37 0.1681 0.0852 0.0532 0.0978         
V38 0.000003   0.000003   0.000003       
L39 
                
M40 0.000003   0.000003   0.000003 0.0154 2 0.011994 
T41 0.185 0.044 0.1191 0.047 0.1978 0.0035 1 0.003056 
T42 0.000003   0.000003   0.000003   2   
H43 0.1877 0.1262 0.000003       3   
L44 0.1856 0.0675 0.0863 0.0681 0.1893 0.01 2 0.007765 
K45 
                
K46 0.000003   0.000003   0.000003   3   
L47 0.000003   0.000003   0.000003 0.0208 1   
K48 0.1874 0.0927 0.1041 0.102 0.2039 0.0099 2 0.008553 
E49 0.1873 0.101 0.1044 0.1051 0.1904 0.0116 1 0.01147 
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S50 0.000003   0.000003   0.000003 0.0276 2 0.026714 
Y51 0.000003   0.000003   0.1661 0.0096 2 0.01517 
C52 0.1903 0.0999 0.1046 0.1114 0.1778 0.0059 2 0.007509 
Q53 
    0.1121 0.0579 0.1896 0.0044 2 0.004073 
R54 0.1856 0.0613 0.1007 0.0736     2 0.004158 
Q55 0.1889 0.051 0.1087 0.0588 0.1923 0.0078 1 0.007765 
G56 0.1913 0.0257 0.1123 0.0262 0.2253 0.005 3 0.003978 
V57 0.1882 0.0602 0.1063 0.0637 0.1948 0.0061 3 0.005508 
P58 
                
M59 
    0.095 0.1588 0.1794 0.0153   0.015949 
N60 0.191 0.0294 0.1106 0.0386     3 0.007916 
S61 0.1878 0.025 0.1073 0.0325 0.1819 0.0034 3 0.004027 
L62 0.1808 0.0166 0.1103 0.0124 0.1507 0.005   0.005 
R63 0.1914 0.0255 0.1119 0.0224 0.1944 0.0066 2 0.006008 
F64 0.189 0.0371 0.1114 0.0422 0.2554 0.0089 1 0.007002 
L65 0.1907 0.0446 0.1087 0.0542 0.1746 0.0039 3 0.004473 
F66 0.2091 0.0074 0.1309 0.0112 0.1522 0.0023 3 0.002024 
E67 0.1921 0.0173 0.1167 0.0185 0.1198 0.0021 3 0.001386 
G68 0.1913 0.0391 0.1089 0.0485 0.2071 0.0055 2 0.005386 
Q69 0.1876 0.0144 0.1159 0.0375     2   
R70 0.1846 0.0403 0.1062 0.0439 0.1713 0.0045 3 0.004085 
I71 0.1887 0.0516 0.1101 0.0652 0.1735 0.0051 3 0.00604 
A72 0.1884 0.0674 0.0999 0.0761 0.1857 0.007 2 0.006071 
D73 
            3   
N74 0.1865 0.1088 0.0995 0.145 0.1795 0.0151 3 0.014777 
H75 0.1808 0.0125 0.1406 0.025     3 0.004411 
T76 0.1689 0.1708 0.1321 0.191     2 0.007136 
P77 
                
K78 0.000003   0.000003       2 0.001967 
E79 0.1937 0.0303 0.1083 0.0346 0.202 0.0028 1 0.002377 
I80 0.1895 0.0445 0.1089 0.0493 0.1657 0.0061 2 0.006836 
G81 0.1878 0.0489 0.1082 0.06 0.2002 0.0067 2 0.006477 
M82 0.1931 0.0339 0.1197 0.0434 0.198 0.0058 3 0.00515 
E83 0.2009 0.0579 0.139 0.079     2 0.018712 
E84 0.1037 0.0057 0.0436 0.0058 0.1757 0.0014 3 0.001386 
E85 0.1882 0.1133 0.1011 0.1319     3 0.007529 
D86 
        0.2255 0.0047 2 0.004411 
V87 0.1867 0.0738 0.1057 0.0789 0.1874 0.0071 3 0.005937 
I88 0.1849 0.0849 0.1072 0.0889 0.1877 0.0077 3 0.008381 
E89 0.1854 0.02 0.1045 0.0243     3 0.004085 
V90 0.1873 0.054 0.1058 0.0614     3 0.003035 
Y91 0.1815 0.0362 0.1124 0.04     3 0.004127 
Q92 0.1894 0.0335 0.1128 0.0343 0.1957 0.0077 2 0.007352 
E93 0.1894 0.0341 0.1112 0.0353 0.1742 0.0053 3 0.005343 
Q94 0.2221 0.0146 0.1349 0.0167     3 0.002203 
T95 
    0.0418 0.0065     3 0.009733 
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Fig. 31: a) Values of ke along the sequence of SUMO1 in titrations of SUMO1 with PIAS derived peptides b) The binding of 
TTRAP_long to SUMO1 being to weak to calculate ke values with an acceptable accuracy, the titration curves have been 
divided in 4 classes. 0 corresponds to line broadening (low ke), 1 to titration curves that appear to reach saturation, 2 to titration 
curve that do not reach saturation and 3 to amino acid that are not affected by TTRAP_long binding.  c) values of ∆max along 
the sequence of SUMO1 in the different titrations. In the case of the titration with TTRAP, the value of ∆ at the highest peptide 
concentrations are given instead of ∆max, since very few amino acids seem to come close to saturation. 
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fig. 32:  Values of ke represented on the structure of SUMO1 (PDB code 1A5R, [Bayer et al, 1998]). Color coding is explained in 
text. High values of ke are in blue, average ones in pink, lower ones in orange. Amino acids with very low values of ke are in 
lime green. All views are from the same angle. Ribbon representations are on the left, surface representation of the same on the 
right. From top to bottom, the values represented are those obtained with PIAS_long, PPIAS, PIAS_short and TTRAP_long.  
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Table 4: Ke (mM) and ∆max  (normalized ppm) values for the amino acids of SUMO2 in different titrations 
  SUMO2 PIAS_long SUMO2 PPIAS 
SUMO2 
PIAS_short 
SUMO2 
TTRAP_long 
Residue ke 
delta 
max ke 
delta 
max ke 
delta 
max ke 
delta 
max 
E8 0.1306 0.0092 0.0745 0.0047     0.0092 0.0053 
G9 0.2837 0.0069             
V10 0.1728 0.0052     0.195 0.0042     
K11 0.062 0.0219 0.0655 0.0137 0.0847 0.0127 0.1436 0.009 
T12 
                
E13 0.0635 0.0262 0.0768 0.0354 0.1042 0.0284 0.0668 0.0126 
N14 0.0687 0.1103 0.0641 0.0993 0.1223 0.1127 0.000002 0.0223 
D15 0.0459 0.0376         0.000002 0.0452 
H16 0.000002   0.000002   0.000002   2.6356 0.1301 
I17 0.000002 0.2942 0.000002   0.000002   0.1317 0.0352 
N18 0.0568 0.1843 0.0594 0.193 0.1174 0.1595 0.4477 0.0894 
L19 0.0662 0.2486 0.000002   0.000002 0.1552     
K20 0.0558 0.1073 0.0764 0.109 0.1134 0.1485 0.935 0.0262 
V21 0.0635 0.0591 0.0855 0.0655 0.1152 0.0469 0.1042 0.0095 
A22 
                
G23 0.0828 0.0147 0.0907 0.0225 0.0952 0.0188     
Q24 0.0615 0.0285 0.0821 0.0267 0.1624 0.0229     
D25 0.0777 0.0123 0.1914 0.0076     0.0221 0.0068 
G26 
        0.0594 0.0035     
S27 0.1744 0.0111 0.0626 0.0045         
V28 0.0683 0.027 0.0762 0.0304 0.1018 0.0396 0.1631 0.0068 
V29 0.0608 0.0618 0.0745 0.067 0.1239 0.0641     
Q30 0.000002   0.000002   0.000002   0.000002   
F31 0.000002 0.2115 0.000002   0.000002   0.1296 0.0152 
K32 
    0.000002   0.1408 0.1175     
I33 0.000002 0.2762 0.000002   0.000002   0.5376 0.1324 
K34 0.000002 0.2214 0.000002   0.000002 0.1809 0.000002   
R35 
                
H36 0.0827 0.1269 0.000002   0.0937 0.0954 0.0744 0.092 
T37 0.000002 0.2314 0.0419 0.2293 0.0891 0.1743     
P38 
                
L39 0.0604 0.1796 0.0505 0.1746 0.1051 0.1552 4.4645 0.1895 
S40 
                
K41 0.0596 0.1023 0.0789 0.1296 0.1242 0.049     
L42 0.000002       0.000002   0.000002   
M43 0.000002 0.1328 0.0774 0.1311 0.1115 0.1155 0.2487 0.0412 
K44 0.0749 0.0649     0.0733 0.0761 0.1646 0.0255 
A45 0.000002 0.1963 0.0634 0.1781 0.000002 0.1834 0.000002 0.0685 
Y46 0.000002       0.000002   0.000002 0.0048 
C47 0.0588 0.0719 0.0698 0.0783 0.1195 0.0772 0.0329 0.0218 
E48 0.1224 0.0182 0.102 0.0235 0.1687 0.0391     
R49 
                
Q50 0.0721 0.0373 0.0773 0.0374 0.1336 0.0336 0.3798 0.0278 
G51 0.0301 0.0246 0.0702 0.014 0.0568 0.0226     
L52 0.0425 0.0065     0.1155 0.0123     
S53 0.0643 0.007 0.0897 0.0057 0.219 0.0396     
M54 
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R55 0.054 0.0345 0.0142 0.0333 0.007 0.0144     
Q56 
    0.0965 0.0072 0.1072 0.0062     
I57 0.0802 0.013 0.0706 0.0148 0.1018 0.0131     
R58 0.0245 0.0141 0.0885 0.011 0.1472 0.013     
F59 
        0.1006 0.0173     
R60 0.0774 0.0362 0.0712 0.0435 0.1048 0.0521     
F61 0.0158 0.0369 0.0817 0.0288 0.108 0.0311     
D62 0.0678 0.0993 0.0864 0.0093         
G63 0.0068 0.0423     0.1216 0.0077 0.0903 0.0305 
Q64 0.0154 0.0225 0.0784 0.0095 0.1623 0.0077 0.0153 0.0194 
P65 
                
I66 
        0.1262 0.0675     
N67 0.0677 0.0803 0.0758 0.075 0.1087 0.0794 3.6735 0.1734 
E68 
    0.0786 0.0716 0.1467 0.0125     
T69 0.0679 0.1065 0.0772 0.1052 0.1076 0.0667 0.1918 0.0201 
D70 0.0479 0.0193 0.0842 0.0143 0.0414 0.027     
T71 0.0464 0.0973 0.0708 0.0889 0.1 0.0815 0.4165 0.0649 
P72 
                
A73 0.000002  0.000002        0.2575 0.0771 
Q74 0.0722 0.0319 0.0658 0.0155 0.1004 0.0149 0.0348 0.0326 
L75 0.0745 0.0418 0.0832 0.0439 0.1636 0.0542     
E76 0.0225 0.0419 0.0956 0.0243 0.122 0.0168     
M77 0.0189 0.0085 0.0737 0.01 0.1296 0.0165     
E78 0.2258 0.1402 0.0076 0.0117     0.0509 0.0889 
D79/F59 0.0647 0.016 0.0121 0.0211         
E80 0.0361 0.0842 0.0784 0.0712 0.1165 0.0555     
D81 
    0.0792 0.0185 0.1488 0.0189     
T82 
    0.0764 0.0115 0.1064 0.0258 0.1752 0.0098 
I83 0.0666 0.0824 0.081 0.0775 0.1114 0.0701     
D84 0.094 0.0244 0.0683 0.0271 0.146 0.0232     
V85 0.0558 0.0973 0.0767 0.0883 0.1042 0.0912 0.2268 0.0245 
F86 0.0621 0.0764 0.0737 0.0849 0.1096 0.0912     
Q87 0.0394 0.0055 0.0864 0.0102   0.0284     
Q88 
                
Q89 
                
T90 0.0607 0.2064 0.0722 0.1957 0.000002 0.1829 1.1078 0.1659 
G91 
            0.000002   
G92 
                
V93 0.1167 0.0841 0.0722 0.0079     0.0193 0.179 
P94 
                
E95 
  0.0192         0.1482 0.0104 
S96 
                
S97 
        0.0638 0.1698 0.000002   
L98 0.0264 0.0139         0.0337 0.0123 
A99 0.0289 0.0119         0.0333 0.0119 
G100 0.1113 0.0137             
H101 
                
S102 
                
F103 
            0.1127 0.0185 
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Fig. 34:  Values of ke represented on the structure of SUMO2 (PDB code 1WM3, [Huang et al, 2004]). Color coding is explained 
in text. High values of ke are in blue, average ones in pink, lower ones in orange. Amino acids with very low values of ke are in 
lime green. All views are from the same angle. Ribbon representations are on the left, surface representation of the same on the 
right. From top to bottom, the values represented are those obtained with PIAS_long, PPIAS, PIAS_short and TTRAP_long.  
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8. Binding to PIAS and TTRAP derived peptides cause similar changes in the 
environment of the amino acids of SUMO1 and of SUMO2 
 
 The comparison of the graphical representation of ∆max along the sequence of 
SUMO2 for the different titrations shows that SUMO2 responds in the same way to 
any of the tested peptides. High ∆max and low ke values are found in the same regions 
of the protein: at the beginning of the β1 strand between His 16 and Lys 20, between  
the second half of the β2 stand and the first half of the α-helix from Phe 31 to Ala 45, 
and between Ile 66 and Phe 86 in the loop region separating the β3- and β4-strands 
(fig. 35a). An overlay of the HSQC spectra obtained with SUMO2 at the end of the 
different titrations show that nearly all SUMO2 N and HN resonances are at the same 
position when SUMO2 is saturated with PIAS_long, PPIAS and PIAS_short.  Similar 
observations can be made with SUMO1: low values of ke occur between His 35 and 
Tyr 51, values of ∆max tend to be higher between His 35 and Gln 53 and between Ala 
72 and Ile 88 (fig. 35b). HSQC spectra are similar at saturation with PIAS_long and 
PPIAS, and HSQC spectrum taken at saturation with PIAS_short is similar to that 
taken at the highest concentration of TTRAP_long.  A comparison of the localization 
a) b)
Fig. 35: regions of  SUMO1 (a) and SUMO2 (b) with amino acids that have high ∆max and low ke value are represented in 
pink on the upper part of the figure. The lower part shows the same structures (1A5R and 1WM3) from the same point of 
view with the coloring scheme presented in the introduction.  
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of the amino acids in intermediate exchange (i.e. those that are most affected by the 
peptide binding) in the different titrations (table 5) shows again a strong similarity 
between the effect of the binding of the different peptides. In this table, those amino 
acids are divided in two classes, depending on whether their HSQC peak broadens 
significantly or completely disappears during the titration. Given that the differences 
in resonance frequencies between the free and bound protein environments are the 
same, in the first case (fast intermediate exchange), the exchange is faster than in 
the second (slow intermediate exchange), corresponding to larger ke values in the 
range of approximation. This distinction shows that the different peptides do not bind 
with the same affinity to SUMO.  
Those amino acids are clearly grouped within and around the second β-strand and 
the α-helix of SUMO. The representation of those amino acids on SUMO1 and 2 
structures (fig. 36) show that they concentrate in a patch of SUMO structure, which is 
the binding site for the SIM on SUMO. However, not all of those amino acids are 
actually part of the binding site. The surface representations of SUMO1 and 2 in fig. 
36 shows that only some of them actually emerge at the surface of SUMO, whereas 
others are completely buried beneath it and cannot therefore make direct interaction 
with the peptides.   
By proceeding so, using Yasara to generate the molecular surface for SUMO1 
and -2 structures, the SIM binding site of SUMO1 is found to consist of His35, Phe36,  
Table 5: Amino acids in intermediate exchange upon binding of SUMO with PIAS and TTRAP derived peptide. The amino 
acids for which the line broadening is not important enough to cause an apparent disappearance of the peak (intermediate 
fast exchange) are signaled by the mention “LB”. Amino acids constituting the binding site described in the text are 
highlighted in Salmon. Positions equivalent in SUMO1 and 2 (see introduction, fig.  2) are in the same row in this table.  In 
the last row, the number of amino acids in intermediate and in intermediate fast (in parenthesis) exchange is indicated. 
SUMO1-PIAS_long SUMO1-PPIAS SUMO1-PIAS_short SUMO1-TTRAP_long SUMO2-PIAS_long SUMO2-PPIAS SUMO2-PIAS_short SUMO2-TTRAP_long
N14 (LB)
D15 (LB)
H16 H16 H16
I22 I22 I22 (LB) I17 I17 I17
L19 (LB) L19 (LB)
I27 I27 I27 (LB)
H35 (LB) H35 (LB) H35 (LB) H35 (LB) Q30 Q30 Q30 Q30 (LB)
F36 F36 F36 (LB) F31 F31 F31
K37 (LB) K32
V38 V38 V38 (LB) I33 I33 I33
K34 K34 K34 (LB) K34 (LB)
M40 M40 M40 (LB) H36
T37
T42 T42 T42
H43 (LB)
K46 K46 K46  K41 (LB)
L47 L47 L47 L42 L42 L42 L42 (LB)
M43 (LB)
S50 S50 S50 A45 A45 (LB) A45 (LB) A45 (LB)
Y51 Y51 Y46 Y46 Y46 (LB) Y46 (LB)
K78 K78 (LB) A73 A73
T90 (LB)
G91 (LB)
S97 S97 (LB)
11 (1) 10 (4) 4 (6) 0 (1) 11 (1) 12 (3) 6 (5) 0 (9)
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Lys37, Val38, Thr42, His43, Lys46 and Ser50. Several amino acids that are in 
intermediate exchange in one or the other titration of SUMO1 can be excluded from 
the binding site. Lys78 is far away from any other amino acid in intermediate 
exchange, and is itself in intermediate exchange only in the PPIAS titration. It is 
therefore not part of the SIM binding site. Ile22, Met40, Leu47 and Tyr51present  
Fig. 36 Amino acids in intermediate exchange in at least 
one of the titrations are represented in color on SUMO1 
(a, 1A5R) and SUMO2 (b, 1WM3). Two views are given 
for SUMO1. Comparison of the ribbon (top) and surface 
(bottom) representations show that some amino acids in 
intermediate exchange have no or very little access to the 
surface of SUMO.  
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nothing or very little of themselves at the surface of SUMO1. They are therefore not 
part of the SIM binding site of SUMO. The case of Ile27 is difficult to decide. It lies out 
of the patch formed by the SIM binding site amino acids, but still very close to it. The 
available data does not allow deciding whether it is part of the SIM binding site, or is 
merely indirectly influenced by the peptide binding. Lys39 is probably part of the 
SUMO binding site, but its HSQC peak overlaps the Glu33 peak in the free protein 
state, making it impossible to decide whether Lys39 is in intermediate exchange or 
not.  
The same procedure shows that the SIM binding site of SUMO2 consists of 
His16, Gln30, Phe31, Lys32, Ile33, Lys34, His36, Lys41 and Ala45. All other amino 
acids in intermediate exchange have side chains that are part of the hydrophobic 
core of SUMO2 directly beneath the SIM binding site. This is recapitulated in table 5.  
 
 
 
 
 
Discussion 
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 1. Studying the properties of peptide binding sites on protein based on NMR titration 
data  
 
The titrations performed for SUMO1 and SUMO2 give us two pieces of 
information on the behavior of most amide groups in those proteins. The first is 
exchange constant ke, which tells how much longer this amino acid spends in one 
environment than in the other. It can often be calculated precisely in the cases where 
the considered amino acids are in fast exchange, and estimated within an order of 
magnitude when the considered amino acid is in intermediate exchange. The second 
information is the magnitude of the chemical shift change (∆max) caused by the 
peptide binding. There is no method available to quantify the structural change 
undergone by a protein based on the change of chemical shift of its amino acids. It 
can be however safely assumed that, in general, a particularly large change of 
chemical shift for an amino means that this amino acid undergoes particularly great 
changes in environment.  
 Both types of information can be combined to determine which amino acids of 
a protein are involved in binding a peptide. Both types of information are to be dealt 
with cautiously. A small value of ke for an amino acid –meaning that it stays 
preferentially in the “bound protein” environment- or a high ∆max –meaning the “bound 
protein” and “free protein” environments are very different for this amino acid- do not 
necessarily mean that this amino acid makes direct contacts with the peptide. It can 
as well make a strong interaction with other amino acids contacting the peptide, or be 
under the influence of overall structural rearrangements caused by the peptide 
binding. Therefore the ke and ∆max values must be carefully analyzed in the context of 
the whole protein to reach conclusions on the details of peptide binding. However it 
can be done better by this method better than by any other existing one because it is 
the only possibility to observe the behavior of single amino acids in solution.  
 
2. The SIM binding surface of SUMO is a “universal plug” through which proteins with 
SIM can interact with SUMO 
 
 As exposed in the results, PIAS- and TTRAP derived peptides bind to the 
same surfaces of SUMO1 and -2, and those surfaces are on similar locations in 
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SUMO1 and -2. It can be concluded from these similarities that PIAS and TTRAP 
derived peptides bind in the same manner respectively to each other to SUMO1 and 
2. It is important to note that the two regions observed to be particularly affected by 
PIAS and TTRAP derived peptide binding are in the folded part of SUMO, which is 
absolutely identical between SUMO2 and SUMO3. There should therefore be no 
substantial differences between the binding of those peptides to SUMO2 and 3.  This 
binding site corresponds well to the one proposed by [Song et al, 2004] for the 
PIAS_long peptide.  
The PIAS and TTRAP derived peptides used in this study being representative 
of the SUMO Interacting Motif (SIM) found in many proteins, it can be safely 
assumed that all those proteins bind to all three SUMO isoforms in a similar way, 
differences in the details of the binding accounting for the different isoform 
specificities and affinities of those proteins, as will be discussed in the following 
sections. Thus, the interaction binding surface of SUMO for PIAS and TTRAP 
appears as a “universal plug” through which SUMO can interact with any protein that 
contains a SIM. The observation by [Chupreta et al, 2005] of a surface determining 
the inhibitory role of SUMO in DNA transcription that corresponds to the SIM binding 
site described here confirms the universality of the SIM/SIM binding site interface for 
mediating SUMO interactions. 
 The hydrophobic core of the SIM is the primary determinant of the binding to 
SUMO. Without it, the binding to SUMO is completely eliminated, as shown by the 
mutation experiments made by Christina Hecker. It can therefore be concluded that 
the hydrophobic core contacts the SIM binding site of SUMO. Since it has a 
sequence typical of a β-strand and that the SIM binding site on SUMO is situated at 
the side of SUMO’s β-sheet, it is probable that the hydrophobic core of the SIM forms 
an intermolecular β-sheet with the β2-strand of SUMO, somewhere between Glu33 
and Lys39. Two structures published after this work was done (the structures of the 
SUMO1/RanGap1/RanBP2/Ubc9 complex [Reverter & Lima, 2005] and of the 
sumoylated Thymine DNA Glycosylase (TDG) [Baba et al, 2005]) comfort this 
hypothesis. In both structures, SUMO1 is in complex with another protein (RanBP2 
and TDG respectively) through an intermolecular β-sheet involving SUMO1’s β2 
strand and a β-strand situated in an unstructured region of the other protein. In the 
case of RanBP2, this β-strand contains the SIM’s hydrophobic placed aside the part 
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of SUMO1’s β2-strand between Val38 to His35 giving a case of a SIM binding to 
SUMO according to the predictions based on the present analysis of NMR data.  
 
3. Mechanisms by which different affinities are observed within a protein 
 
 Analysis of participation to SUMO’s surface of the amino acids in intermediate 
exchange in the different titrations has shown that some amino acids that are strongly 
affected by peptide binding can not make direct contacts with the peptide itself (Ile22, 
Met40, Leu47 and Tyr51in SUMO1; Leu 42, Met 43 and Tyr 46 in SUMO2). The 
strong effect of peptide binding on them is indirect: those amino acids have 
sidechains buried in the hydrophobic core of SUMO, in immediate proximity of the 
SIM binding site. The structural changes in the SIM binding site caused by peptide 
binding are changes of environment for the amino acids situated directly beneath it. 
The mechanism responsible for this also explains the surprising fact that different ke 
values are observed within a protein when it binds to a ligand. A priori, if the ligand 
binds at a certain frequency, and the protein-ligand complex has a certain lifetime, 
then each of the amino acids of the protein should change environment with this 
frequency and lifetimes. One has, however, to take into account that a protein is not a 
rigid object. Each of the amino acids of a protein is able to move relatively to the 
others, and to adopt a conformation that is stable in its environment. Therefore, a 
change of position of an amino acid X in response to ligand binding does not 
necessarily modify the position of all others, but merely constitutes a change of 
environments for the neighboring amino acids. An amino acid Y in the neighborhood 
of X has now two possible conformations: the “normal” conformation and the 
conformation adapted to the modified environment. Y will exchange between both 
with frequency and lifetimes depending on the stability of both conformations and on 
the rate at which X’s conformation is modified, not on that rate only. This accounts for 
the fact that the ke varies from amino acid to amino acid in the titrations of SUMO 
with PIAS and TTRAP derived peptides. This also explains why some amino acids 
are in intermediate exchange upon titration with PIAS- and TTRAP derived peptides 
although they can make no direct contacts with those peptides: those amino acids 
have side chains buried in the hydrophobic core of SUMO directly beneath the SIM 
binding site, a situation which makes them particularly sensitive to the structural 
rearangments of the SIM binding site induced by peptide binding.   
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4. The PIAS and TTRAP derived peptides bind with different affinities to SUMO1 and 
SUMO2/3  
 
 Until this point, the analysis of the binding of the studied peptides to SUMO 
has relied on values of the exchange constant ke for individual amino acids, which 
indicates the preference that those amino acids have for the “bound protein” 
environment over the “free protein” environment when the peptide is present. To 
interpret those results in a manner that is relevant to cellular contexts, one has to 
quantify the binding of proteins to SUMO in a molecule-wide manner. It is, 
fortunately, quite easy to have an idea of the KD (dissociation constant) of a peptide 
for SUMO when the ke values are known: SUMO as a whole cannot exchange faster 
between its bound and free state than its amino acid that does so the slowest. 
Hence, the value of KD for a peptide and SUMO is lower than the lowest value of ke 
found in SUMO with this peptide. It might, of course be lower: conceivably, the 
different amino acids in the binding site might interact independently with the peptide. 
In that case, the situation would be that of an array of binding sites. In such 
situations, the affinity of the array for the ligand is higher than the affinity of each of 
the array’s elements. There is no practical way to investigate those possibilities using 
NMR measurements, which limits us to an upper-limit estimation of the KD of the 
used peptides for SUMO. However, the fact that the KD measured by isothermal 
calorimetry (ITC) by [Song et al, 2004] (∼6 µM) for SUMO1 with the PIAS_long and 
PIAS_short peptides are in the same order of magnitude than the ke measured by 
NMR for the same peptide, showing that at least in the case of SUMO-SIM binding 
the ke values allow a fairly good estimation of the KD.  
The table 5 shows that even though the peptides studied here all bind through 
the same interface to SUMO they affect SUMO to different extent. The number of 
amino acids in fast intermediate exchange and in slow intermediate exchange is 
different in each titration.  This means that, even though the estimated ke values for 
the binding site amino acids are very similar (varying between 2 and 10 µM in each 
titration where it could be estimated), there are some differences in the affinity of the 
different peptides to SUMO.  
SUMO1 binds very poorly to TTRAP. No detectable change in SUMO1 HSQC 
spectra can be seen upon addition of either TTRAP_short_Cside or 
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TTRAP_short_Nside. Some changes are observed upon addition of TTRAP_long, 
but are too little to allow a precise estimation of the ke values. In this titration, only His 
35 is observed to be in intermediate fast exchange, meaning that its ke should be no 
smaller than 3µM (value observed in the titrations of SUMO1 with PIAS derived 
peptides). Furthermore the ke derived from the few TTRAP_long/SUMO titration 
curves that appear to approach saturation are never smaller than 0,12 mM (values 
obtained for Gly28 and Glu 49).  Hence, the KD of SUMO1 for TTRAP long must lie 
somewhere between 3 and 120 µM). Much more extensive changes were observed 
with all three PIAS derived peptides, and all three cause several SUMO1 amino acids 
to be in intermediate exchange, meaning that they have higher affinity to SUMO1 
than the TTRAP derived peptides. Comparing the numbers of SUMO1 amino acids in 
slow- and fast intermediate exchange (see table 5) in the titrations of SUMO1 with 
PIAS derived peptides shows that PPIAS has a higher affinity to SUMO1 than 
PIAS_long, which in turn binds better to SUMO1 than  PIAS_short does. In each 
case, the lowest measured ke value is 3µM, corresponding to a KD in this range. 
Comparing the ke values for the amino acids in fast exchange in the different 
titrations lead to the same classification: in term of affinity to SUMO1, 
(TTRAP_short_Nside / TTRAP_short_Cside) < TTRAP_long << PIAS_short < 
PIAS_long < PPIAS.  
Comparison of the number of amino acids in slow intermediate exchange and 
in fast intermediate exchange in the different SUMO2 titrations (see table 5) shows 
that the PIAS derived peptides have a higher affinity to SUMO2 than the TTRAP 
derived peptides. TTRAP_long has a higher affinity to SUMO2 than 
TTRAP_short_Nside and TTRAP_short_Cside, which both bind poorly to SUMO2. 
There appears to be little difference in the affinity of the three studied PIAS derived 
peptides to SUMO2, the Kd being in each case around 2µM. Comparing the ke 
values for the amino acids in fast exchange in the different titrations lead to the same 
classification: in term of affinity to SUMO2, (TTRAP_short_Nside / 
TTRAP_short_Cside) < TTRAP_long < (PIAS derived peptides).  
Comparing the binding of each peptide to SUMO1 and -2 is only partly 
possible. TTRAP_long clearly binds better to SUMO2 than to SUMO1 (several amino 
acids are in intermediate exchange in the former and only one in the latter upon 
binding to TTRAP_long), confirming the results obtained by Christina Hecker with 
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GST-pulldown experiments. Such comparison for the other peptides is not possible, 
the number of amino acids in intermediate exchange being similar in both isoforms.  
 
5. PIAS_short and PIAS_long bind to SUMO1 by a distinctive 2-steps mechanism  
 
 For a ( Protein + Ligand → Protein•Ligand ) binding, it is expected that the 
titration curve has the shape presented in fig. 30 for SUMO2 This expected shape is 
actually observed for the amino acids in fast exchange in all titrations but those of 
SUMO1 with PIAS_long and PIAS_short. For those two titrations, titration curves 
have a clearly two stepped shape, as shown in fig. 30. Several reasons can be 
invoked for this unexpected behavior.  
The first possibility is that there are several binding sites for PIAS_long and 
PIAS_short on SUMO.  
The fact that the titration curves obtained for SUMO1 with PPIAS have the 
expected shape point at two alternative explanations. When SUMO1 titrations with 
PIAS and PPIAS are compared, it appears that the only significant difference in ke 
between both is for Lys37, which is in fast exchange with PIAS_long and in fast-
intermediate exchange with PPIAS. This shows that the phosphate group of PPIAS 
likely binds to SUMO1 in the neighborhood of this lysine (the same difference is 
observed for SUMO2’s Lys34 which is equivalent to SUMO1’s Lys37, confirming this 
hypothesis). Examination of SUMO1 and SUMO2 structures in this region show that 
the end of the β2 strand is much more bent in SUMO1 than is SUMO2, and that 
SUMO1’s Lys39 sidechain points into the binding site (it is coplanar with the β-sheet) 
whereas the equivalent Lys34 in SUMO2 points away from the SIM binding site (it is 
perpendicular to the β-sheet). Therefore it can be proposed that the negatively 
charged phosphate group of PPIAS interacts with the positively charged Lys39 of 
SUMO1 causing a conformation change favorable for PPIAS binding. The absence of 
phosphate group in PIAS_long would make this transition more difficult to achieve. A 
high PIAS_long concentration would be required to maintain SUMO1 in the binding-
favorable conformation, producing the observed two-steps titration curve. The 
conformation Lys34 in SUMO2 being already favorable to PIAS derived peptides 
binding, whether phosphorylation is present or not on the peptide does not matter 
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much in their binding. Unfortunately, the observation of the behavior of Lys39, which 
is critical, is made impossible by HSQC peak overlapping.  
The last possibility is that the two-steps titration curves observed for titrations 
of SUMO1 with PIAS_long and PIAS_short is that those peptides have to compete 
with the N-terminal tail of SUMO1 for binding to the SIM binding site. The N-terminal 
tail of SUMO1 is observed to form a βstrand parallel to β2 in the complex between 
SUMO1 and the E1 enzyme Sae1/Sae2 [Lois & Lima, 2005; this complex is 
presented in ore detail in the introduction], thus blocking access to the SIM binding 
site. It can be hypothetized that PPIAS would compete more efficiently with the N-
terminal tail of SUMO for the SIM binding site because its phosphate group would 
allow it to interact better with the lysins (particularly Lys37) of the binding site, making 
the effect of the competitive binding on the titration curves less noticeable. This 
hypothesis will have to be tested by investing the effect of removing the N-terminal 
tail of SUMO1 on PIAS derived peptides binding.  
 Of the three possible explanations for the two-step binding of PIAS_long and 
PIAS_short to SUMO1 (multiple binding sites, favorable conformation changes more 
efficiently induced by PPIAS than by PIAS_long, competition of the peptide with the 
N-terminal tail of SUMO1), the two latest –which are not exclusive- are the most likely 
to be relevant. The other option raises two difficulties. There is no evidence of a 
second binding site for PIAS_long and PIAS_short in the titrations of SUMO1 with 
those peptides, and it is not likely that PIAS_short has two binding sites for SUMO (it 
is too small for this). Besides, two binding sites would be likely to increase the affinity 
of unphosphorylated PIAS derived peptides for SUMO, instead of decreasing it.  
 
6. Contribution of the amino acids surrounding the SIM to SUMO binding 
  
 The region of SUMO that binds to the SIM has now been defined. But how 
does the SIM bind to SUMO, and which roles play its different elements? The 
apparently obvious way to answer those questions is the production of a structure of 
a SUMO-SIM complex. This is, however, rather impractical. A crystal structure would, 
even if crystals could be produced at all, be difficult to interpret because the 
crystalline arrangement might force the peptide to adopt a particular conformation 
that is not relevant of its behavior in solution. A NMR structure would require large 
amounts of isotope labeled synthetic peptide which cost would be prohibitive. This 
Conclusion 
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limits us to the information that can be gained from the effects of the peptide binding 
on SUMO. 
 As discussed earlier, the sequence of the SIM and the localization of the 
binding surface on SUMO show that SIMs bind to SUMO by forming an 
intermolecular β-strand with the β2 strand of SUMO. This gives two possible relative 
orientations for the SIM and SUMO. In the case of the binding of PIAS- and TTRAP 
derived peptides to SUMO, several facts hint at a parallel orientation. First, the 
binding of those peptide has no particular effect on the C-terminal side of the β2 
strand of SUMO, whereas is affects several amino acids in the loop region between 
the β2 strand and the α-helix. As seen before, SUMO1’s Lys37 and the 
corresponding SUMO2’s Lys34 are in intermediate exchange with PPIAs and not with 
the other peptides, indicating that the phosphate group of PPIAS is in proximity of 
these lysines when PPIAS binds to SUMO. Finally, the amino acids in the loop 
between the β3 and β4 strands of SUMO are affected by the binding of PIAS_long 
and PPIAS, but not by PIAS_short, indicating that the C-terminal part of PIAS_long 
and PPIAS –which is absent in PIAS_short- interacts with this part of SUMO. Those 
three observations support the conclusion that the core of PIAS-derived peptides is 
parallel to the β2 strand of SUMO in the PIAS-SUMO complex. It is more delicate to 
draw conclusions for TTRAP, but the fact that several amino acids in the loop 
between the β3 and β4 strands of SUMO2 have relatively high affinity for 
TTRAP_long points to a parallel orientation of this peptide and the β2 strand of 
SUMO.  
 The large decrease in affinity of PIAS and TTRAP derived peptides when the 
amino acids surrounding the SIM are absent shows that those amino acids should 
play a role in the SIM binding to SUMO. The binding of the PIAS_long and PPIAS, 
but not of PIAS_short, affects the loop region between SUMO’s β3 and β4 strands 
(particularly Lys78 of SUMO1 and Ala73 of SUMO2, which are in intermediate 
exchange with those peptides). It can therefore be concluded that the amino acids in 
C-term of the hydrophobic core of SIM’s PIAS contributes to SUMO binding by 
interacting with this loop.  
SUMO proteins appear to be in most cases tags used to mediate binding 
between their target protein and an interaction partner. This mechanism and the 
diversity of SUMO targets suggested that there might be a common mechanism by 
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which those interaction partners bind to SUMO. Several different SUMO Interaction 
Motifs (SIM) have been proposed in the literature. Analysis of the sequence of the 
proteins already known to interact with SUMO as well as of those found by Christina 
Hecker led to propose a SIM sequence that reconciles the different proposals 
previously published.  According to this analysis, the SIM consists in a hydrophobic 
core and a tract of negatively charged amino acids separated by one of several 
serine phosphorylation sites. Experimental evidence showed that the hydrophobic 
core of the SIM is crucial for the interaction with SUMO.  
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The work presented here showed what role the different elements of the SIM play in 
binding to SUMO. The proposal that the hydrophobic core of the SIM forms an 
intermolecular β-sheet with the second β-strand of SUMO has been confirmed by the 
structure published by [Reverter and Lima, 2005]. However, though earlier studies 
[Song et al, 2004] suggested that they might be unimportant, this work shows that the 
amino acids flanking the hydrophobic core of the SIM play an important role the 
affinity of the SIM for SUMO. Thus, the SIM appears as an interaction interface that 
can be fine tuned by evolution. The tract of negatively charged amino acids 
influences the affinity of the SIM for SUMO by interacting with the loop region 
between the β3 and β4 strands of SUMO. A certain number of SIM have their 
negatively charges in N-term of the hydrophobic core instead of having them in C-
term of it like in PIAS. This suggests that the position of those amino acids relatively 
to the hydrophobic core determines the orientation of the SIM relatively to SUMO. 
Further experiments will be done to examine this possibility. A further regulation of 
the affinity of the SIM for SUMO is assured by phosphorylation of serines surrounding 
the hydrophobic core of the SIM. In the cellular context, unlike the negatively charged 
amino acids, this regulation can be changed during the life of the SIM, opening the 
possibility of activation of SUMO interactions by phosphorylation of SIMs. In this 
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Fig. 37: Binding of PIAS_long to SUMO1 (the titration curve obtained for His 43 of SUMO1 is plotted). The peak path is 
proportional to the ratio [PIAS_long]free/([PIAS_long]total. This ratio considerably increases when the [PIAS]total increases 
above ~0,2 mM 
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regard, the sigmoid curves observed for the binding of unphosphorylated PIAS to 
SUMO1 show that it behaves like a concentration-sensitive switch. The fraction of 
PIAS bound to SUMO quickly increases when a threshold PIAS concentration (~200 
µM for a SUMO1 concentration of 300 µM) is reached (fig. 37). This threshold effect 
is absent in the binding of phosphorylated PIAS to SUMO1. At the low PIAS 
concentrations likely to be encountered in cells, PIAS can bind to SUMO only in its 
phosphorylated state. Thus the observations presented here show the structural 
detail of how phosphorylation “turns on” a protein for protein-protein interaction. 
Those variations in the SIM offer an exceptional opportunity to study the mechanisms 
protein-protein interactions in their finest details on biologically relevant molecules.  
The interaction surface on SUMO for the SIM functions as a universal plug 
through which a variety of protein can be recruited. It is remarkable that Ubiquitin, to 
which SUMO is closely related, also has such a universal plug, the Ile 44 patch. This 
patch is an hydrophobic surface at the surface of Ubiquitin to which a variety of 
proteins bind. Despite their similar function, the SIM binding site and the Ile 44 patch 
are located on different areas of the ubiquitin fold. Furthermore, whereas the SIM is a 
well conserved short (~20 amino acids) sequence that can inserted in a protein 
domain, the proteins binding to the Ile 44 patch of Ubiquitin do not appear to have 
any common structural element for doing so. Instead, a proteins use various domains 
(see [Hicke et al, 2005] for review) to interact with the Ile 44 patch of Ubiquitin. Those 
differences are just another illustration of the variety of solutions selected by 
evolution to achieve a similar task.  
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